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Svensk sammanfattning 
Intermediärfilament (IF) är en del av cellens stödstruktur – cellskelettet. IF bildar 
nätverk av repliknande strukturer som sträcker sig genom cellen. Dessa filament 
är uppbyggda av proteinfamiljen IF-protein, protein som kännetecknas av 
förmågan att bilda filament med sig själva eller andra IF-protein. Förutom att de 
ger cellen stöd har IF-proteiner även andra uppgifter såsom att t.ex. delta i 
cellsignalering och styra hur gener uttrycks. Vi känner till ungefär 70 olika IF-
protein hos människan. Mutationer i de gener som kodar för IF-protein har 
visats orsaka flertalet obotliga sjukdomar. 
IF-proteinet lamin A bygger upp ett nätverk innanför cellens kärnmembran. 
Detta nätverk fungerar som ett fysiskt skydd för kärninnehållet genom att ta upp 
stötar och förhindra att kärnan deformeras. Dessutom har lamin A även andra 
funktioner; t.ex. interagerar det direkt med kromosomerna och styr deras 
placering samt hur den genetiska koden läses. I min avhandling undersöker jag 
hur modifikationer av lamin A påverkar dess rörelse och lokalisering i cellkärnan. 
Under musklernas utveckling och regeneration,  d.v.s. läkning efter en skada, 
uttrycks IF-proteinet nestin. I mitt arbete har jag undersökt hur frånvaro av 
nestin påverkar muskelcellers differentiering och hur muskler regenererar. 
Resultaten visar att även om nestin inte är nödvändigt för att muskelstamceller 
ska omvandlas till mogna muskelceller så leder frånvaro av nestin till en rubbad 
muskelbalans. Möss som saknar nestin har mindre muskelmassa än 
motsvarande kontrollmöss. Vi visar även att i avsaknad av nestin undergår 
musklerna spontan regenerering utan att ha skadats, och efter en skada läker 
musklerna långsammare. Denna studie visar för första gången att nestin har en 
viktig roll i musklerna och att nestin är speciellt betydelsefullt för att skydda 
muskler mot stress samt för att reglera läkningsprocessen efter en skada. Jag 
presenterar även resultat som visar att avsaknad av nestin leder till ökad 
variation i testikelstorlek. Tillsammans styrker dessa resultat teorin att en av IF-
proteinernas funktioner är att skydda celler mot stress. 
IF-proteiner har egenskaper som gör att de är svåra att studera i 
däggdjursmodeller, samtidigt som cellkulturer inte kan användas för att studera 
alla aspekter av IF-funktioner. Vi har därför utvecklat en bananfluga som 
uttrycker det humana IF-proteinet vimentin, en modell som kan användas i 
fortsatt forskning och därmed minskar behovet av musmodeller.   
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Abstract 
Intermediate filaments are part of the cytoskeleton and nucleoskeleton; they 
provide cells with structure and have important roles in cell signalling. The IFs 
are a large protein family with more than 70 members; each tightly regulated and 
expressed in a cell type-specific manner. Although the IFs have been known and 
studied for decades, our knowledge about their specific functions is still limited, 
despite the fact that mutations in IF genes cause numerous severe human 
diseases.  
In this work, three IF proteins are examined more closely; the nuclear lamin A/C 
and the cytoplasmic nestin and vimentin. In particular the regulation of lamin 
A/C dynamics, the role of nestin in muscle and body homeostasis as well as the 
functions and evolutionary aspects of vimentin are investigated. Together this 
data highlights some less well understood functions of these IFs.  
We used mass-spectrometry to identify inter-phase specific phosphorylation 
sites on lamin A. With the use of genetically engineered lamin A protein in 
combination with high resolution microscopy and biochemical methods we 
discovered novel roles for this phosphorylation in regulation of lamin dynamics. 
More specifically, our data suggests that the phosphorylation of certain amino 
acids in lamin A determines the localization and dynamics of the protein. In 
addition, we present results demonstrating that lamin A regulates Cdk5-activity. 
In the second study we use mice lacking nestin to gain more knowledge of this 
seldom studied protein. Our results show that nestin is essential for muscle 
regeneration; mice lacking nestin recover more slowly from muscle injury and 
show signs of spontaneous muscle regeneration, indicating that their muscles are 
more sensitive to stresses and injury. The absence of nestin also leads to 
decreased over-all muscle mass and slower body growth. Furthermore, nestin 
has a role in controlling testicle homeostasis as nestin-/- male mice show a greater 
variation in testicle size.  
The common fruit fly Drosophila melanogaster lacks cytoplasmic IFs as most 
insects do. By creating a fly that expresses human vimentin we establish a new 
research platform for vimentin studies, as well as provide a new tool for the 
studies of IF evolution.     
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1 Introduction 
Cells are remarkable. Although all the cells in multi-cellular organisms originate 
from a single cell and contain the same genetic information, the cells are 
incredibly different in appearance, function, and life-span. The neuronal cells, 
for example, are renewed at a very low rate with a life span of decades, whereas 
the cells of the intestinal epithelium are changed at a high rate, living only for 
days. These differences are a result of the process of differentiation, where a cell 
transforms from an un-specialised state to a specific specialised cell-type. 
Differentiation, and indeed all other processes in a cell, is dependent on the cell 
receiving and responding to signals from the outside, as well as from the inside 
of the cell itself. Such signalling requires the cells to have a certain degree of 
structure in order to be efficient.  
To be able to keep its shape, to move, transport molecules to different 
compartments and keep its organelles organised, a cell is dependent on the 
cytoskeleton. The cytoskeleton is an internal cellular scaffold consisting of 
protein filaments. These filaments are divided into three groups; microfilaments, 
microtubules and intermediate filaments (IFs), which all form distinct but 
interacting networks throughout the cell.  
The IFs, which are the subject of study in this work, constitute a diverse protein 
family with both structural and signalling functions in the cell. Although 
mutations of IFs have been proven to cause many diseases, no treatments for 
these often devastating syndromes have been developed. This is partly due to our 
lack of knowledge of the basic functions of IFs and how these proteins are 
regulated. The expansion of the basic research regarding IFs can, thus, have a 
major impact on development of novel therapies.  
In this thesis, the goal has been to examine and employ three different models 
designed to unravel IF dynamics and functions. Phospho-proteomics in 
combination with site-directed mutagenesis was employed to investigate how 
phosphorylation affects lamin A, and we have been able to show that the 
movement and localization of lamin A both are dependent on the protein’s 
phosphorylation status. The second project in this thesis looks into the roles of 
nestin in vivo using nestin knockout mice. More specifically, we show that nestin 
has an impact on muscle healing after injury at the organism level, rather than 
having a primary role in the differentiation of individual muscle cells. The third 
Introduction 
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study develops a new research model, a fruit fly expressing human vimentin, 
which can be used for research regarding both IF function and evolution. 
Together these studies provide new insights into the regulation and physiological 
impact of IFs.     
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2 Review of the Literature  
2.1 Intermediate filaments 
IFs are a large protein family consisting of more than 70 distinct proteins. All the 
IF-proteins are characterized by a structurally conserved rod domain flanked by 
variable head and tail regions. The most characteristic property of an IF-protein 
is the ability to assemble into filaments, either by itself to form homopolymers, 
or in conjunction with another IF-protein to form heteropolymers; reviewed in 
(Herrmann et al., 2007).   
The first x-ray structure of an IF, although the concept of IFs was yet to be 
invented at that time, was solved from thinly sectioned wool, consisting mainly 
of keratins (Astbury and Street, 1932). The authors used the x-ray data as well as 
chemical and mechanical studies of wool to propose that keratin(s) is a 
filamentous structure that consists of repetitions of the same structural subunit. 
This hypothesis is in its essence in line with our current knowledge of IF 
structure. 
The long, cell spanning filaments of cytoplasmic IFs are built up of protein 
monomers that assemble into polymers. Some of the IFs only assemble if another 
IF is available for co-polymerization: nestin, for example, always forms 
heteropolymers with vimentin, desmin or α-internexin (Sjöberg et al., 1994b; 
Steinert et al., 1999) while other filaments, like desmin and vimentin, also can 
form homopolymers. The process of turning monomeric protein units into long 
filaments is complex but seemingly spontaneous. The first step is the formation 
of subunit dimers, which then assembly into anti-parallel tetramers. The 
tetramers are fused into unit-length filaments, which are further longitudinally 
annealed into filaments. The last step is the radial compaction of the newly 
formed filaments (Figure 1) (Godsel et al., 2008; Herrmann et al., 2009). The 
assembly of lamins differs from the assembly of cytoplasmic IFs. The lamin 
molecules first form parallel dimmers, which then fuse head-to-tail to form 
tetramers, also called protofilaments. Three or four protofilaments then build up 
the lamin filaments (Ben-Harush et al., 2009). The lamin filaments also differ 
from the cytoplasmic IFs by forming a meshwork, in contrast to long filaments 
(Aebi et al., 1986). 
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Figure 1. The cytoplasmic IF assembly process. The assembly starts with IF 
monomers assembling into parallel dimers. The dimers then form anti-parallel 
tetramers. Eight tetramers build up unit length filaments (ULF), which fuse into 
long filaments that are radially compressed to form the mature filaments. In the 
cell the filaments undergo subunit exchange, but the exact mechanisms behind this 
process remain unknown. 
 
The IFs are divided into six groups based on their structural relationship, 
expression patterns and functions. Group I and II, the acidic and basic keratins, 
are the largest groups. Keratins are the typical IFs of epithelia, and they are also 
the building blocks of hair, nail, horn and hoofs. Due to their structure the 
keratins always form heterodimers consisting of one type I and one type II 
monomer. The third group contains vimentin, desmin, GFAP and peripherin. 
Group III proteins can form both homopolymers and heteropolymers with type 
IV IFs. Group IV in turn comprehends the neurofilaments (NFs), nestin, α-
internexin, synemin and syncoilin. These proteins are very diverse, but are 
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grouped due to their evolutionary relationship with NFs. The lamins in group V 
differ from other IFs in that they localize to the nucleus. The most archaic 
function of the lamins was probably to protect the nucleus from physical stress; 
later lamin proteins have acquired a more complex function. The novel IFs in 
group VI, filensin and phakinin, are found in the lens. 
IFs are found in all metazoan organisms (Erber et al., 1998) and, in addition, IF-
like proteins have recently been identified in other eukaryotes, such as an 
amoeba and water mold (Kollmar, 2015). While the simpler organisms express 
only lamins, the numbers and complexity of the IFs increase in higher order 
organisms. An exception to this is the arthropods which, with only one known 
exception, express only lamins and no cytoplasmic IFs (Herrmann and Strelkov, 
2011). In general invertebrates have only one B-type lamin, whereas A-type 
lamins only exist in vertebrates, reflecting lamin A as an evolutionary more 
recent protein (Peter and Stick, 2012). Interestingly, the cytoplasmic IFs found in 
lower organisms are more closely related to lamins than to cytoplasmic IFs in 
higher organisms (Weber et al., 1989). This indicates that a B-type lamin was the 
first IF to evolve, and that this founder IF gradually gave rise to cytoplasmic IFs 
and later to A-type lamins (Peter and Stick, 2012; Peter and Stick, 2015).  
2.1.1 Cellular functions of IFs 
The function of IFs has been a much debated topic. Initially, IFs were considered 
to be structural proteins providing the cell with mechanical stability. Over time, 
many other more diverse functions of IFs have been discovered. After the 
introduction of patient genomes sequencing in order to identify disease causing 
mutations, numerous diseases caused by mutations in IF genes have been 
discovered. This has led to a change in the view of the functions of IFs, as many 
of the diseases cannot be explained by mere disruption of mechanical scaffolds. 
The diseases are diverse and affect many different organs; even mutations in the 
same IF can give rise to completely different phenotypes. The largest group of 
IF-related diseases identified so far are the laminopathies, which are caused by 
mutations in the lamin genes, particularly affecting lamin A. Examples of 
diseases directly caused by mutated IFs and the organs affected are listed in 
Table 1. 
Nevertheless, the structural functions of IFs are essential for everyday life. 
Keratins are needed for hair and nails, as reflected in the fact that mutations in 
the hair keratins influence hair structure. Other types of keratins have barrier 
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and tissue integrity related functions. Mutations in the epithelial keratins 5 or 14 
give rise to the blistering skin disease epidermolysis bullosa simplex (EBS), in 
which epithelial cell layers do not attach firmly enough to each other (Coulombe 
et al., 2009).   
Furthermore, IFs take part in organizing the cytoplasm and the positioning of 
organelles. For example both vimentin and desmin have been shown to bind to 
mitochondria (Milner et al., 2000; Nekrasova et al., 2011). In the absence of 
desmin, the mitochondria in striated muscles are disorganized and often 
aggregate; furthermore, they show extensive proliferation as well as degradation 
in heart muscle (Capetanaki, 2002; Milner et al., 2000). Vimentin has also been 
shown to directly modulate mitochondrial function, and other IFs are postulated 
to harbour similar functions (Chernoivanenko et al., 2015). Vimentin also 
contributes to the stiffness of the cytoplasm and to the organization of organelles 
by reducing random movement of particles in the cytoplasm (Guo et al., 2013). 
Vimentin is present at the focal adhesions, where it plays a critical role in 
transferring the mechanical force from the cell membrane to the cytoplasm and 
in activating signalling pathways in response (Gregor et al., 2014). Interestingly, 
vimentin also protects the nuclei from mechanical stress by decreasing the 
nuclear deformability in a yet un-characterized manner, which is not dependent 
on direct interaction with the nuclear lamins (Neelam et al., 2015).  
IFs also regulate the shape and motility of cells. Disruption of the vimentin 
network by micro-injection of a dominant negative vimentin mutant that 
disassembles the vimentin network leads to a dramatic change in cell shape. 
When the network is collapsed in mesenchymal cells, the cells lose their 
elongated shape and gain a round epithelial shape instead (Mendez et al., 2010). 
Similarly, introduction of vimentin filaments in epithelial cells leads to a 
mesenchymal cell shape (Mendez et al., 2010). Almost all IFs have been linked to 
cellular migration, depending on the filament and the cell type either promoting 
or inhibiting cell movement; reviewed in (Chung et al., 2013; Leduc and Etienne-
Manneville, 2015). General and specific functions of IFs are outlined in Figure 2. 
These observations show that the IF-networks have diverse roles as organizers of 
cellular compartments and signalling molecules, and that they are protectors 
against mechanical stress and transducers of mechanical messages. This diversity 
in functions is also the basis for the very different phenotypes of IF-related 
diseases. A mutation in one region of an IF may interfere only with a very 
specific function of that protein, whereas a mutation in another region, or 
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indeed in very close proximity, can interfere with a totally different function. The 
most prominent example of this is the numerous disease-causing mutations in 
lamin A: for example the D300N mutation is associated with the premature 
aging disease atypical Werner syndrome, whereas the L302P mutation only two 
positions away gives rise to muscular dystrophy (UMD-LMNA at www.umd.be). 
This shows that knowledge of all the functions of a specific IF is vital for being 
able to design specific treatments against IF-related diseases.      
Table1 Examples of diseases directly caused by mutations in IF-genes 
Diseases caused 
by IF mutations 
IF involved Organ 
affected 
References  
Epidermolysis 
bullosa simplex 
K5, K14 skin (Coulombe et al., 
2009) 
Pachyonychia 
congenital 
K6a,  K6b, K16, 
K17 
skin, nail (Smith et al., 2005) 
Desmin-related 
myopathy 
desmin 
skeletal 
muscle, heart 
muscle 
(van Spaendonck-
Zwarts et al., 2011) 
Alexander 
disease 
GFAP CNS (Quinlan et al., 2007) 
Charcot-Marie-
Tooth disease NF-L PNS 
(Jordanova et al., 
2003; Liem and 
Messing, 2009) 
Cardiomyopathy lamin A  heart muscle (Lu et al., 2011) 
Cataract filensin, phakinin, 
vimentin 
lens (Müller et al., 2009; 
Perng et al., 2007) 
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Figure 2. Overview of IF functions. General functions of IFs are outlined (top) 
and some of the specific functions of lamin A/C and nestin are listed (below).  
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2.1.2 Dynamics of IFs 
When studied in fixed cells, IF-networks give the impression of being robust and 
stiff. From studies of fluorescently labelled IFs in live cells it is, however, clear 
that the IFs are highly dynamic structures with constant exchange of subunits 
and rapid reorganisation of filaments in response to stimuli. The different IFs 
form independent, partially over-lapping or totally over-lapping networks in the 
cell and can have very different dynamic properties. The vimentin and keratin 
8/18-networks, for example, show completely independent dynamics even 
within the same cell (Yoon et al., 2001). This fact supports the idea that the 
different IFs have different functions in the cell.  
2.1.2.1 The transport and dynamics of cytoplasmic IFs  
The dynamics of IF-networks are still far from fully understood. Similarly, many 
things remain to be learned about how the networks are formed in vivo. The use 
of fluorescently tagged proteins has made it possible to follow how IF subunits 
are transported in the cell, as well as how the networks themselves move and 
exchange subunits.  
The microtubule network has been proven to be important for the movement 
and transport of several different IFs. IF-subunits or short filaments are 
transported along the microtubules throughout the cell. The microtubule-based 
transport is rapid and bi-directional, but also interrupted by frequent and 
sometimes long pausing (Wang et al., 2000; Wöll et al., 2005).  
The axons of neuronal cells are rich in the different isoforms of NFs. As the NF 
subunits are only produced in the cell body, the content of NFs in the axon must 
be dependent on a transport mechanism. It has been shown that NF-particles are 
transported along the microtubules from the cell body to the periphery of the 
axon, and that the motor proteins kinesin and dynemin are responsible for this 
microtubule dependent NF transport (Prahlad et al., 2000; Uchida et al., 2009). 
The transport of NFs is dependent on phosphorylation in an indirect manner; 
phosphorylated NF subunits have lower affinity for the motor proteins and 
higher affinity for other NFs; reviewed in (Shea and Chan, 2008). This gives the 
cell means to regulate when and where to un-couple the NF subunits from the 
microtubules and, thus, co-ordinate the building and specific intracellular 
localisation of the NFs. 
In a similar manner to NFs, short vimentin filament subunits have been shown 
to move along microtubules at high speed (Robert et al., 2014). Still, this 
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transport only affects a small part of the vimentin present in a cell, as not more 
than 2% of the total vimentin pool was found to be associated with microtubules 
(Robert et al., 2014). Vimentin also interacts with the actin-network, which 
prevents the movement of vimentin (Robert et al., 2014).  
Individual filaments in keratin 8/18-networks show a wave-like movement, as 
has been shown with the use of GFP-tagged keratin 18 (Yoon et al., 2001). 
Keratins are assembled into proto-filaments in the cell periphery and then 
assemble into mature filaments as they are transported towards the nucleus. 
Along the way some filaments are degraded, and the subunits transported back 
to the periphery for reuse in new filaments (Kölsch et al., 2010; Leube et al., 
2011). The movement of the keratin particles, as well as the movements of the 
entire keratin network, is dependent on microtubules and independent of actin 
filaments (Windoffer and Leube, 1999). However, keratins are also moving along 
actin filaments in the cell periphery (Wöll et al., 2005).  
Together these results show that at least some, but more probably all of the IFs 
are dependent on other cytoskeletal elements for network forming and for 
transportation of building blocks to specific parts of the cell. However, much of 
the details of the IF dynamics as well as how they are regulated still remain 
unknown.    
As further discussed below in the lamin section, phosphorylation is a key post-
translational modification (PTM) for nuclear IF dynamics. While understanding 
of the mitotic breakdown of the nuclear lamina has been a major driving force 
behind the studies of lamin phosphorylation, the phosphorylation of cytoplasmic 
IFs has been studied in a less coherent manner. It is nevertheless clear that both 
the mitotic and non-mitotic dynamics of cytoplasmic IFs are regulated by 
phosphorylation. For example, the breakdown of the vimentin network during 
mitosis has been shown to be driven by phosphorylation; reviewed in (Goldman 
et al., 2012; Sihag et al., 2007). Consistent with this, mutation of the mitotic 
phosphorylation sites to an un-phosphoryable form leads to increased 
tetraploidy, as the intact vimentin network obstructs proper cytokinesis 
(Matsuyama et al., 2013; Tanaka et al., 2015). Phosphorylation is also important 
for IF dynamics in a non-mitotic context: lipid signalling has for example 
recently been shown to induce phosphorylation dependent re-organisation of 
both keratin 8 and vimentin networks (Busch et al., 2012; Hyder et al., 2015). 
The lipid- induced ERK-dependent phosphorylation of S431 in keratin 8 leads to 
a shift in the keratin 8/18 network, from cell spanning filaments to formation of 
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a perinuclear network. This in turn promotes epithelial cancer cell migration 
(Busch et al., 2012). In case of vimentin, the lipid signalling induces an effector 
Rho-associated kinase (ROCK) dependent phosphorylation of S71. The vimentin 
S71 phosphorylation in turn leads to retraction of the vimentin network and 
inhibition of cell migration (Hyder et al., 2015). That the lipid signalling induced 
phosphorylation of keratin 8 promotes cell migration, and that phosphorylation 
of vimentin induced by the same signalling inhibits migration, can be explained 
by the different cell-lines used in the studies. It is important to note that the cells 
used by Hyder et al. lack keratin 8 and, thus, cannot have a keratin 8 
phosphorylation induced response (Hyder et al., 2015).  
2.1.3 Signalling properties of IFs  
IFs have many properties that make them excellent scaffolding molecules. They 
can sequester signalling molecules and keep them inactive, or active, at different 
parts of the cell, and they can also bring together different molecules, thus 
enabling them to form active complexes.    
When a cell receives a signal, the message must be forwarded from the receiving 
part of the cell to the rest of it. This process needs to be fast and accurate, a fact 
especially obvious in peripheral nerve cells, where the distance between the tip of 
the axon and the cell body can be several centimetres or even metres. When a 
distal part of an axon is damaged, Erk1/2 is phosphorylated and bound to soluble 
vimentin fragments, which are generated by calpain-mediated cleavage of newly 
synthesized vimentin subunits. This complex then binds to importin β and is 
subjected to retrograde transport along the microtubules to the cell body 
(Perlson et al., 2005). When the complex reaches the cell body, phospho-Erk is 
released and can activate its targets. The binding of phospho-Erk to vimentin is 
dependent on calcium: when the complex reaches the cell body with lower 
calcium concentration than the periphery, Erk is released (Perlson et al., 2006). 
During the transport vimentin protects phospho-Erk from dephosphorylation 
and degradation due to physical protection of the molecule (Perlson et al., 2006). 
This process is an example of the signalling properties of two not yet well-
studied IF-functions: the role of soluble IFs and IFs as chaperones. 
Another example of an IF with signalling functions is keratin 14, which  has been 
shown to up-regulate the JNK/MAPK-pathway (Wagner et al., 2013). Similarly, 
desmin has been identified as essential for the activation of JNK during 
mechanical muscle fiber stress (Palmisano et al., 2015) As kinases in the 
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JNK/MAPK-pathway are known to phosphorylate several IFs, including keratins 
(Toivola et al., 2002), it implicates a feedback loop, where the expression of one 
IF can, through JNK-signalling, regulate the structure of others and itself. These 
examples demonstrate how the IFs can work in cell signalling, and also show the 
limitations of our knowledge about cross talk between different IFs.  
During cancer metastasis, as well as during physiological processes such as 
wound healing, cells undergo epithelial-mesenchymal transition. During this 
transition the cells lose their epithelial phenotype and gain a mesenchymal 
phenotype, including higher motility and the ability to invade. At the same time 
the cells lose their epithelial keratins and gain vimentin expression (Kokkinos et 
al., 2007). The gain of vimentin is not a mere marker of the mesenchymal state; 
vimentin has also a direct role in facilitating the transition.  This since vimentin 
induces Axl, a kinase that promotes cellular motility (Vuoriluoto et al., 2011). 
Vimentin also regulates Erk-activity in cancer cells; vimentin sustain Erk-activity 
which in turn leads to expression of Slug, an EMT-inducing factor (Virtakoivu et 
al., 2015).   
2.2 Lamin A/C 
2.2.1 Splicing and processing of lamin A  
In contrast to the other IFs, lamins are found in the nucleus, where they form the 
nuclear lamina – a thin fibrous layer inside the inner nuclear membrane. Lamin 
A and C are splice variants produced by the LMNA-gene, a gene which also gives 
rise to the less common splice variants lamin A Δ10 (Machiels et al., 1996), lamin 
A Δ50 or progerin (Eriksson et al., 2003), and the germ cell-specific lamin C2, 
that so far has only been found in rodents (Furukawa et al., 1994).  
Lamin A is expressed as a precursor protein, prelamin A, which undergoes a 
series of modifications to become the mature protein. The C-terminus of 
prelamin A ends with a CAAX-box, and the cysteine residue in this motif is 
rapidly farnesylated. After the farnesylation step the AAX-sequence is cleaved off 
and the farnesylcysteine is methylated. In the last step, the 15 last amino acids of 
prelamin A are enzymatically cleaved by ZMPSTE24, giving rise to mature lamin 
A; reviewed in (Young et al., 2006). The lamin A/C processing is described in 
Figure 3.  
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In Hutchinson-Gilford progeria syndrome (HGPS), a mutation in the LMNA-
gene leads to abnormal splicing and the production of progerin instead of lamin 
A, with dramatic consequences for the affected individual. Due to the differential 
splicing, progerin lacks the ZMPSTE24 cleavage site and thus remains 
constitutively farnesylated. Progerin has recently been shown to be produced in 
healthy individuals at certain periods during development, and during aging, 
although this splicing is strictly controlled in a yet unknown manner 
(Bökenkamp et al., 2011; Luo et al., 2013). Lamin C, in contrast to lamin A, is not 
processed (Dechat et al., 2008). Compared to lamin A, lamin C lacks exons 11 
and 12 and has six unique amino acids in the C-terminus. In lamin C2 the N-
terminal head region is replaced by a shorter sequence. Very little is known 
about the regulation of the differential splicing and the expression of the 
isoforms in vivo, or their functions for that matter. In a recent study lamin C has 
been identified as the predominant A-type lamin in the brain, due to the down-
regulation of prelamin A by miR-9, a miRNA expressed at high levels in the 
brain (Yang et al., 2015). This shows that there are several mechanisms 
regulating the balance between lamin A and C, and that these mechanisms might 
play different roles in different tissues.  
To elucidate the functions of the different prelamin A processing steps an array 
of mouse models have been created, reviewed in (Davies et al., 2011). The exact 
functions of the prelamin A processing still remains unknown; this as mice 
expressing mature lamin A directly without the prelamin A processing steps are 
physiologically normal (Coffinier et al., 2010). Similarly, mice expressing only 
lamin C, but no lamin A, are seemingly normal (Fong et al., 2006), in contrast to 
mice lacking both lamin A and C (Kubben et al., 2011; Sullivan et al., 1999). 
These results suggest that the non-farnesylated lamin C can compensate for 
lamin A, and that prelamin A processing is not needed for normal nuclear 
envelope targeting of neither lamin A nor lamin C. 
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Figure 3. Lamin maturation. Alternative splicing of the lamin A/C mRNA gives 
rise to prelamin A and lamin C, as well as the less common forms prelamin A Δ10 
and lamin C2. Prelamin A undergoes a series of c-terminal modifications and 
cleavages, outlined in the left part of the figure, to yield mature lamin A. Lamin C, 
in contrast, is translated as the mature protein. 
 
2.2.2 Lamin PTMs 
Given the many diverse functions of lamin A and the numerous binding 
partners reported, as well as the tissue specific diseases caused by mutations in 
this ubiquitously expressed protein, it is clear that expression-independent ways 
to regulate its functions must exist. PTMs constitute one part of this regulation, 
offering a possibility for the cell to regulate proteins in a fast and direct manner, 
as an opposite to the regulation of transcription and translation. Lamin A/C is 
heavily posttranslationally modified, but many of the identified modifications 
have not been studied beyond their identification. In the following sections, I 
describe some of the more commonly studied lamin PTMs in more detail. 
2.2.2.1 Lamin SUMOylation 
Small ubiquitin-like modifier (SUMO) is a polypeptide that can be covalently 
attached to lysine residues on proteins by an E3-ligase. In lamin A K201, located 
in the rod-domain, has been identified as a SUMO2 target (Zhang and Sarge, 
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2008). This modification has also been shown to be clinically significant, as the 
cardiomyopathy-causing mutations E203G and E203K disturb the SUMO 
consensus sequence, resulting in un-SUMOylated lamin A (Zhang and Sarge, 
2008). In the tail of lamin A, K420 and K486 have been reported to be modified 
by SUMO1 (Simon et al., 2013) and K520 also by SUMO3 (Galisson et al., 2011). 
Interestingly, the SUMOylation of the lamin A tail is also affected by mutations, 
in this case by the Dunnigan-type familial partial lipodystrophy-causing K486N 
and G465D mutations. These mutations decrease tail SUMOylation  without 
affecting rod SUMOylation (Simon et al., 2013). Yet the function of lamin 
SUMOylation remains unknown. Simon et al (2013) speculate that the 
attachment of SUMO to the lamin A tail interferes with protein interactions 
dependent on these regions, and thus the signalling or scaffolding functions of 
lamin A.  
2.2.2.2 Lamin phosphorylation 
Phosphorylation is the addition of a phosphate group to a serine, threonine, 
tyrosine or, un-commonly, histidine residue of a protein. This process is 
performed by enzymes called kinases, while the reverse process, the removal of a 
phosphate group, is performed by phosphatases. Phosphorylation affects 
proteins in many ways: it can for example turn on or off an enzyme, target a 
protein for degradation or influence protein localisation, solubility and 
organisation.  
Phosphorylation is one of the major PTMs of IFs, and has been shown to 
influence numerous IFs and their functions (Snider and Omary, 2014). Lamin 
A/C is no exception from this: with more than 70 unique phosphorylation sites 
identified, phosphorylation is the most abundant PTM of lamin A/C (Simon and 
Wilson, 2013). Phosphorylation of lamin A/C has mostly been studied in the 
context of mitosis, as the breakdown of the nuclear envelope, a requirement for 
mitosis, is dependent on lamin phosphorylation. During mitosis, both A- and B-
type lamins are phosphorylated by Cdk1 at highly conserved sites surrounding 
the rod domain (Dessev et al., 1990; Dessev et al., 1991; Heald and McKeon, 1990; 
Peter et al., 1990). These residues are primarily S22 and S392 in human lamin A 
and S23 and S393 in lamin B1. 
During mitosis the lamin A and lamin B networks are disrupted at different 
kinetics. The A-type lamins are disassociated from the inner nuclear membrane 
earlier than the B-type lamins (Georgatos et al., 1997). Lamin A seems to be 
soluble in the nucleoplasm before the breakdown of the nuclear membrane and 
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is later found throughout the cytoplasm, whereas B-type lamins remain attached 
to the nuclear envelope for a longer time (Georgatos et al., 1997). In the last stage 
of mitosis, the B-type lamins too are found soluble throughout the cytoplasm.  
After mitosis the nuclear lamina is re-assembled. Even here, B- and A-type 
lamins show differences: B-type lamins associate with the still condensed 
chromosomes and rapidly build up a solid lamina, while A-type lamins remain 
in the nucleoplasm, and are slowly incorporated into the lamina (Moir et al., 
2000). The phosphorylation of lamins is a dynamic process, where the different 
sites show different occupancy during the cell cycle (Kuga et al., 2010). The 
dynamics of phosphorylation can provide an explanation for the different de- 
and re-assembly dynamics of the lamins during mitosis. 
2.2.3 Structural and mechanical functions of lamin A/C 
The genetic information of cells is well protected inside the nucleus, and 
particularly the cage of lamins gives the nucleus strength to withstand physical 
deformation (Liu et al., 2000). The A- and B-type lamins work together to 
provide the nucleus with strength and flexibility. B-type lamins are thought to 
provide the nucleus with rigid but still flexible walls which will withstand 
physical impact. A-type lamins, on the other hand, act as a viscous fluid to 
absorb shock (Swift et al., 2013).  
A-type lamins have been shown to be the major lamins contributing to nuclear 
stiffness, whereas lamin B1 seemingly does not influence nuclear stiffness 
(Lammerding et al., 2006). The same study also showed that lack of lamin A/C 
leads to nuclear blebbing and deformed nuclei at a greater rate than the loss of 
lamin A only or B1. The results offer yet another piece of evidence for the 
hypothesis that Lamin C can, at least to some extent, compensate for loss of 
lamin A.  
Recently, the role of lamin A as a mechanosensor, sensing and responding to 
changes in the cells’ physical environment, has been brought to attention 
(Isermann and Lammerding, 2013; Swift et al., 2013). Cells grown on stiffer 
substrates have higher lamin A-expression and stiffer nuclei than cells grown on 
softer substrates (Swift et al., 2013). In other words, the cells respond to their 
mechanical environment by regulating lamin levels and, thus, adapt their nuclear 
stiffness to anticipated mechanical stress. The lamin levels also correlate with 
differentiation pathways: mesenchymal stem cells with higher lamin A 
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expression are more prone to differentiate into bone, whereas the same cells with 
lower lamin A levels are more prone to become adipocytes (Swift et al., 2013). By 
adjusting the substrate stiffness it is thus possible to affect the lamin A levels and 
ultimately differentiation processes. The discovery that cells can react to their 
environment in such a direct and consequential way also gives insight into the 
complex factors regulating cell fate in the body. Stem cells proliferating on the 
hard substrate of bone are more prone to become bone, whereas stem cells 
proliferating in the soft environment of adipose tissue are more prone to become 
adipocytes. 
Nuclear stiffness also has direct consequences for a migrating cell; when a cell 
squeezes through the tissue, for example during lymphoid metastasis of tumour 
cells, the cells are subjected to mechanical stress. Cells with too stiff nuclei have 
been shown to be unable to migrate through capillaries, due to the stiff nucleus 
physically hindering the migration (Harada et al., 2014). Indeed, overexpression 
of lamin A hampers the migration of neutrophils (Rowat et al., 2013). On the 
other hand, cells with too soft nuclei, due to down-regulation of lamin A, also 
have problems migrating, as the soft nuclei are torn by the mechanical stress, 
leading to apoptosis of the cells (Harada et al., 2014).  
Lamin A can also influence migration and mechanosensing both by regulating 
transcription factors (Ho et al., 2013) and by directly influencing the cells’ 
physical properties (Harada et al., 2014; Rowat et al., 2013; Swift et al., 2013). 
These results show that lamin A has a significant role as a signalling hub, 
receiving and forwarding signals from the environment as well as from inside the 
cell, but also by affecting the outcomes of the signals.  
2.2.4 Nucleoplasmic lamin A  
Although the majority of lamin A is found in the nuclear lamina, 
immunofluorescence as well as fluorescently tagged lamin A has been used to 
demonstrate the presence of a nucleoplasmic lamin A/C pool (Dechat et al., 2010; 
Gesson et al., 2014; Shimi et al., 2008). The nucleoplasmic lamin A/C fraction is 
more mobile than the lamina associated fraction, and can further be divided into 
two distinctive groups: the fast-moving and the slow-moving (Shimi et al., 2008). 
The functions of these different dynamics are yet unknown, but probably reflect 
diverse, yet undefined, functions of the nucleoplasmic lamins. There is indeed 
growing evidence that the nucleoplasmic pool of lamin A has important roles. 
For example, the nucleoplasmic lamin A interacts with lamina-associated 
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polypeptide 2 isoform alpha (LAP2α) and retinoblastoma protein (pRb), which, 
in turn, also interacts with LAP2α (Dechat et al., 2000). The interaction between 
lamin A, LAP2α and pRb is believed to regulate the activity of pRb and cell cycle 
progression (Gesson et al., 2014; Naetar and Foisner, 2009). Loss of LAP2α and 
nucleoplasmic lamin A impairs cell cycle exit and differentiation, whereas over-
expression of LAP2α leads to premature differentiation (Dorner et al., 2006; 
Naetar et al., 2008). The interaction between lamin A and LAP2α is also essential 
to keep lamin A in the nucleoplasm; loss of LAP2α has been shown to lead to 
significant reduction of nucleoplasmic lamin (Naetar et al., 2008). During 
myogenic differentiation there is also a correlation between loss of 
nucleoplasmic lamin A and down-regulation of LAP2α expression (Markiewicz 
et al., 2005). 
2.2.5 Laminopathies - peculiar diseases that give insights into lamin 
functions   
Laminopathies, the diseases caused by mutations in the lamin genes, are the 
largest group of IF-associated diseases. The phenotypes of these diseases vary 
tremendously, reflecting the many processes which lamins influence (Table 2). 
Table 2 examples of laminopathies.  
Laminopathy 
Organ 
affected 
Symptom 
Familial partial 
lipodystrophy (Dunnigan 
type) 
Fat tissue 
Abnormal body fat 
distribution, increased risk 
for type II diabetes 
Emery-Dreifuss muscular 
dystrophy 
Heart and 
skeletal muscle 
Muscle wasting, heart failure 
Dilated cardiomyopathy 1A Heart Sudden death, heart failure 
Hutchinson-Gilford progeria 
syndrome 
Whole body 
Premature aging, 
atherosclerosis 
Charcot-Marie-Tooth 
disease type 2B1 
Peripheral 
nerves 
Muscle atrophy in lower 
limbs 
 
There are different theories trying to explain the effects of lamin mutations: the 
structural hypothesis, the gene regulation hypothesis and the impaired stem cell 
function hypothesis; reviewed in (Davidson and Lammerding, 2014; Gesson et 
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al., 2014; Ho and Lammerding, 2012). The structural hypothesis focuses, as the 
name suggests, on the structural properties of lamin A. As previously mentioned, 
one of the functions of lamin A is to provide the nucleus with physical strength. 
A disruption of the lamin A network due to a mutation could, thus, affect the 
nuclear structure and mechanics. Muscle cells, particularly cardiac muscle cells, 
are subjected to severe physical stress as they contract and relax during our daily 
life. Muscles are therefore among the first organs to show symptoms of altered 
structural or mechanical properties of proteins. The structural hypothesis can 
therefore be used to explain the symptoms of laminopathies affecting cardiac 
and skeletal muscles. 
The gene regulation hypothesis is based upon the fact that lamin A/C interacts 
with DNA and regulates transcription; reviewed in (Camozzi et al., 2014; Dechat 
et al., 2008). Any mutation which interferes with these processes can affect 
downstream targets, with unexpected consequences for the cell. For example, the 
lamin A/C R482W mutation causing Dunnigan type familial partial 
lipodystrophy affects the activity of the transcription factor sterol response 
element binding protein 1 (SREBP1) (Vadrot et al., 2015). The mutated lamin 
interacts less with SREBP1, and the lost interaction in its turn leads to increased 
activity of SREBP1 as well as enhanced transcription of an array of its target 
genes.  
The stem cell hypothesis is based upon the fact that lamin A is known to regulate 
stem cell populations. Mice expressing progerin, the HGPS-causing form of 
lamin A, in their keratinocytes have fewer stem cell-like keratinocytes 
(Rosengardten et al., 2011). Similarly, over-expression of progerin in human 
bone marrow derived stem cell-like cells leads to decreased proliferation and 
decreased expression of stem cell marker proteins (Pacheco et al., 2014). Apart 
from affecting stem cell populations, lamin A also affects differentiation and is 
for example critical for myogenic differentiation (Frock et al., 2006). 
Disturbances in stem cell numbers and differentiation will affect both specific 
tissues and the whole organism, explaining why the laminopathies have such 
dramatic phenotypes.  
These hypotheses do not exclude each other: impaired differentiation can for 
example be due to altered gene expression, which in turn can be due to altered 
physical lamina properties. Most probably a combination of the proposed 
hypotheses and yet unknown factors is the causative element of laminopathies.  
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2.3 Nestin 
2.3.1 Nestin structure and polymerisation  
Nestin is a less studied IF and little is known about its functions, although it is 
commonly used as a stem cell marker. Nestin was first identified in radial glial 
cells with the use of the monoclonal antibody rat-401 (Hockfield and McKay, 
1985). Later nestin was discovered to be expressed in, and became used as a 
marker for neuroepithelial stem cells, from which the protein also got its name 
(neuroepitelial stem cell protein) (Lendahl et al., 1990).  
The nestin gene consists of 4 (human) or 5 (mouse) exons encoding a 1621 
(human) or 1864 (mouse) amino acids long protein with a molecular mass of 
around 200 kDa. Nestin is characterized by its unusually long tail, consisting of 
sequence repeats. The longer murine form is due to loss of a number of the 
repeats in human (Dahlstrand et al., 1992). Three different isoforms of nestin 
have been identified so far: apart from the full length protein two truncated 
forms lacking either the repeats or the repeats and part of the rod domain have 
been described (Su et al., 2013; Wong et al., 2013).  
Like the keratins, nestin cannot form filaments on its own. It has been shown to 
form heteropolymers with vimentin and α-internexin in vitro, and although 
nestin forms homo-oligomers, in vitro these cannot form filaments  (Steinert et 
al., 1999). In vivo nestin co-localizes with desmin, and these IFs form an 
indistinguishable network (Sjöberg et al., 1994b). In vimentin-negative SW13 
cells, the expression of nestin leads to diffuse cytoplasmic localisation of the 
protein, whereas expression of nestin in corresponding vimentin positive cells 
gives rise to a nestin-vimentin network with clearly distinguishable filaments 
(Marvin et al., 1998). The loss of a nestin network in the absence of vimentin has 
also been confirmed in cells from vimentin-/- mice, underscoring the importance 
of binding partners for the formation of nestin filament (Eliasson et al., 1999).  
2.3.2 Regulation of nestin gene and protein 
During development, nestin is expressed in numerous tissues; apart from the 
developing CNS, nestin is also found in developing skeletal and cardiac muscle 
cells, in the developing eye and in the blood vessels; reviewed in (Wiese et al., 
2004). In the healthy adult nestin expression is limited to very few, specific 
regions such as the podocytes (Chen et al., 2006) and the pancreatic islets 
(Hunziker and Stein, 2000). Following injury nestin is re-expressed in muscle 
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(Vaittinen et al., 2001) and brain (Lin et al., 1995). This expression pattern hints 
that nestin expression is tightly regulated. 
The regulation of IF expression is a very rarely studied subject, and nestin is no 
exception to this with only few studies regarding its expression existing. A 
simplified overview of the regulation of nestin, as described below, is outlined in 
Figure 4. The introns in the nestin gene have been proven to be essential for its 
expression patterns. Elements within the first intron regulate the expression in 
muscle, and elements within the second intron regulate expression in brain 
(Zimmerman et al., 1994). However, the nestin GFP mice, where the second 
nestin intron is utilized for driving a GFP transgene, have a more widespread 
expression pattern, leaving the exact mechanisms behind nestin gene regulation 
still unsolved (Walker et al., 2011).The nestin promoter is unusually short and 
lacks a functional TATA-box, but contains two SP1-sites that are needed for 
transcription (Cheng et al., 2004). The tumour suppressor p53 targets nestin 
expression by preventing the binding of Sp1 and Sp3 to the nestin promoter 
(Tschaharganeh et al., 2014). Mutation of p53, as is common in many cancers, 
interferes with this process and enables nestin expression (Tschaharganeh et al., 
2014). The nestin gene has also been shown to be regulated by epigenetic factors; 
histone acetylation is needed for activation of nestin expression, whereas 
demethylation is not strictly needed but plays a role in proper regulation of 
expression (Han et al., 2009).  
The transcription of nestin has been more thoroughly characterized in neurons, 
but some information about the regulation of nestin in muscle exists. In the 
mouse myoblast cell line C2C12, the first intron of nestin has been shown to 
regulate the transcription; furthermore, the transcription factor MyoD binds this 
intron and enhances the protein expression (Zhong et al., 2008). Forced 
expression of MyoD in the nestin negative mouse pre-adiopocyte cell line 3T3-
L1 leads to nestin expression, even though myoblasts without MyoD-expression 
do express nestin, indicating that additional elements regulate the nestin gene 
(Kachinsky et al., 1994). The fact that nestin gene activity has been detected in 
quiescent satellite cells (Day et al., 2007), where MyoD is not detectable, 
confirms the complexity of nestin regulation in muscle. 
Recently it has become well accepted that not only the transcription, but also the 
degradation of mRNA is a heavily regulated and important part of the cell’s 
protein production control. Several studies show that nestin mRNA is targeted 
by miRNAs. In nasopharyngeal carcinoma cells, nestin is targeted by miR-940 
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(Ma et al., 2014). The miR-940-induced down-regulation of nestin correlates 
with apoptosis and cell cycle arrest, reinforcing the finding that nestin protects 
cells against apoptosis (Sahlgren et al., 2006). Nestin mRNA has been shown to 
be a target for miR-125b in neuronal stem and progenitor cells where up-
regulation of miR-125b correlates with down-regulation of nestin and 
differentiation  (Cui et al., 2012). In addition to this, nestin mRNA has also been 
shown to be targeted by miR-432 in differentiating neuroblastoma cells (Das and 
Bhattacharyya, 2014). As more miRNA sequences are discovered, our 
understanding of this form of regulation of nestin, as well as other IFs, its 
complexity and co-ordination with other types of gene- and protein-regulation 
will without a doubt expand.   
Apart from the gene expression, protein stability and degradation are important 
regulatory steps. This is especially apparent when it comes to IFs, as these 
proteins normally are very stable; the half-life of NFs in axons has been 
suggested to be in the time frame of weeks (Nixon and Logvinenko, 1986). 
During differentiation of neuronal stem cells nestin expression is rapidly lost, 
and there is evidence that this is through notch-dependent targeting of nestin for 
proteosomal degradation (Mellodew et al., 2004). The tail region of nestin is 
important for driving the protein-degradation, as mutants lacking various parts 
of the C-terminal region have a significantly longer half-life (Sahlgren et al., 
2006). 
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Figure 4. Simplified overview of nestin regulation. The short nestin promoter 
contains two Sp1-sites needed for transcription. Regulatory elements in the first 
and second intone of the nestin gene drive tissue specific expression. Several 
microRNA-molecules have been shown to promote the degradation of nestin 
mRNA. The tail region of nestin protein is needed for the ubiquitin-induced 
proteasomal degradation of nestin.  
2.3.3 Functions of nestin 
Still, three decades after the discovery of nestin, its molecular and physiological 
functions remain mainly unclear. Genetic depletion of nestin revealed that 
whereas nestin is not essential for survival of mice, it plays a role in proper 
organization of neuromuscular junctions (Mohseni et al., 2011). Using an in vivo 
knockdown strategy Yang et al. showed that nestin is needed for organization of 
acetylcholin receptors at the postsynaptic membrane of neuromuscular junctions 
(NMJ) (Yang et al., 2011). These studies did not, however, look into the role of 
nestin outside the NMJs. Apart from these studies a second knockout mouse has 
been reported (Park et al., 2010). The phenotype of this mouse strain differs 
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from the other reported strains as these mice undergo embryonic lethality at a 
high rate, with only rare knockout animals surviving until birth (Park et al., 
2010). The lethality was reported to be due to extensive apoptosis of cells in the 
CNS. In both knockout models the first exon of nestin is targeted, but the 
targeting vectors differ. As knockdown of nestin (Yang et al., 2011) gives an 
identical phenotype as one of the knockout models (Mohseni et al., 2011), the 
embryonic lethality reported in the second knockout model (Park et al., 2010) is 
more probably the result of  an off-target effect of the recombination vector used. 
During myogenic differentiation, nestin regulates Cdk5 activity by forming a 
scaffold for Cdk5 and p35 (Sahlgren et al., 2003). Nestin in turn is regulated by 
Cdk5 phosphorylation: when nestin is phosphorylated by Cdk5 it loses its 
filamentous structure and becomes more soluble (Sahlgren et al., 2003). The 
phosphorylation also leads to decreased interaction between nestin and p35, 
showing the ability of Cdk5 to regulate its own activity through regulating 
nestin’s scaffolding capacity.  
It has been shown that nestin facilitates the disassembly of vimentin filaments 
during mitosis, but the importance of this process remains unclear, as vimentin 
positive, nestin negative cells undergo mitosis without problem (Chou, 2003). 
During mitosis nestin filaments are rearranged due to phosphorylation of nestin 
by Cdk1 (Sahlgren et al., 2001). This rearrangement also affects other proteins 
binding to nestin; for example, the binding between nestin and phosphatase and 
actin regulator 4 is disrupted during mitosis due to the phosphorylation of nestin 
(Cho et al., 2014). The interactions between nestin/vimentin and insulin 
degrading enzyme are also dependent on filament phosphorylation (Chou et al., 
2009). 
2.3.4 Nestin in muscle 
Soon after the initial discovery of nestin its expression was identified in skeletal 
muscle during development (Sejersen and Lendahl, 1993) and in regenerating 
muscle fibers of Duchenne/Becker muscular dystrophy patients (Sjöberg et al., 
1994a). During the early stages of limb bud development nestin is found in 
mesenchymal cells, but as development proceeds nestin becomes restricted to 
differentiating muscle cells (Wroblewski et al., 1997). After birth nestin is down-
regulated and desmin becomes the primary IF in muscle fibers (Carlsson et al., 
1999; Sejersen and Lendahl, 1993). In the normal adult muscle nestin expression 
is limited to NMJ and myotendinous junctions (MTJ) (Carlsson et al., 1999; 
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Vaittinen et al., 1999). Inmouse models that express GFP under the control of 
the second intron of the nestin promoter satellite cells are GFP labelled in vivo, 
indicating that at least the nestin locus is active in these cells (Day et al., 2007). 
When a muscle injury occurs, the expression of nestin is initiated,  and nestin 
protein is found both in newly differentiated myoblasts and in regenerating 
myofibers (Vaittinen et al., 2001). This up-regulation of nestin has been 
identified in several different injury models, such as denervation (Vaittinen et al., 
1999), cut injury and in situ necrosis (Vaittinen et al., 2001). In a transplantation 
model, which reflects ischemic injury due to transient loss of blood supply, it was 
shown that newly formed myotubes and fibers express nestin (Čížková et al., 
2009). This suggests that expression of nestin is a general feature of muscle 
regeneration, regardless of the type of injury initiating the regeneration.  
Despite the fact that nestin expression has been detected in muscle disease 
(Sjöberg et al., 1994a) and that nestin is found in regenerating muscle (Vaittinen 
et al., 1999), almost nothing is known about the functions of nestin in muscle in 
vivo. In vitro nestin has been shown to function as a regulator of the muscle 
differentiation process. Down-regulation of nestin by siRNA leads to accelerated 
differentiation of the C2C12 myoblast cell line. Conversely over-expression of 
nestin inhibits the differentiation process (Pallari et al., 2011). This effect is due 
to nestin’s ability to regulate Cdk5 activity through modulation of p35 turnover; 
blockage of Cdk5 activity overrides the nestin over-expression effect (Pallari et 
al., 2011).    
2.4 Models to study IFs 
2.4.1 Transgenic mice as models to study IFs 
Genetic engineering of mice has led to many breakthroughs in the biological 
sciences. The functions of IFs have, thus, been studied with the use of knockout 
and knock-in mice. The mouse as a model organism as well as some of the 
properties of IFs have made these studies difficult and, in some cases, 
unsuccessful. Despite these shortcomings, knockout and knock-in mice as well 
as mice expressing fluorescently tagged proteins are invaluable tools in the IF-
field.  
2.4.1.1 Knockout approaches  
The knockout of a protein is the disruption of the corresponding gene by 
recombinant DNA technology, which makes all cells in the animal lack the 
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protein. In conditional knockouts the gene of interest is disrupted in specific 
cells constitutively or after external induction; this is achieved by first producing 
animals with the gene of interest flanked by loxP-sites, and then by crossing 
these with animals expressing Cre-recombinase in a cell-specific manner or 
under an inducible promotor. The recombinase will then cleave the DNA at the 
loxP-sites, leading to knockout of the gene only in the specific cells.    
Although knockout mice have given much information about IF functions, 
many questions have not been answered with these animal models. One of the 
main problems with IF-knockout mice is that many IFs have partly overlapping 
functions and, thus, can compensate for each other in vivo. Another problem is 
that many phenotypes are subtle and require detailed investigation to be 
identified. Thirdly, the phenotypes caused by lack of an IF may become apparent 
only after stress and are therefore not detected in laboratory animals at normal 
circumstances. A few examples of IF-knockout mice are discussed in more detail 
below to give insights into some of the challenges with the knockout approaches.  
Epidermolysis bullosa simplex is a devastating human disease caused by 
mutations in keratin 5 or 14. Thus it was a great advance that the knockout of 
keratin 14 led to a blistering phenotype resembling the human disease, and that 
these mice could be used for enhancement of the understanding of the disease 
(Lloyd et al., 1995). Normally, keratin 14 forms heterofilaments with keratin 5: 
the knockout of keratin 14 would, thus, also disturb the function of keratin 5. 
However, investigation of the mice lacking keratin 14 led to the discovery that 
keratin 5 can bind to keratin 15 in the absence of its normal binding partner, and 
thus still form filaments. This unusual keratin 5-15 filament partly dampens the 
effect of keratin 14 knockout, as shown by the early postnatal death of keratin 5 
knockout mice which lack both 5-14 and 5-15 filaments (Peters et al., 2001).  
In contrast to the keratin 14 knockouts, mice lacking vimentin were first 
reported to develop without a phenotype (Colucci-Guyon et al., 1994). However, 
later studies have shown that vimentin is important for many cellular functions, 
and that the mice develop phenotypes in response to various stresses such as 
wound healing (Eckes et al., 2000) or reduction of kidney mass (Terzi et al., 
1997). The combination of GFAP and vimentin knockout has a more profound 
effect on the healing of injured CNS than the single knockouts (Pekny et al., 
1999). This shows that vimentin and GFAP partially can compensate for each 
other in the CNS. 
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Lamin A/C was first knocked out in 1999 by disruptions of exons 8-11 of the 
lamin gene (Sullivan et al., 1999). Later the original lamin knockout mouse was 
shown to express a truncated form of lamin (lamin A Δ8-11) (Jahn et al., 2012). 
A lamin A knockout constructed with a gene trap strategy has several phenotypic 
differences compared to the original mouse (Kubben et al., 2011). Both these 
mice strains show reduced weight gain, skeletal and cardiac muscle myopathy, 
and early death (Kubben et al., 2011; Sullivan et al., 1999). Mice homozygous for 
the genetrap allele, however, die at an age of 16-19 days, whereas the lamin A 
Δ8-11 mice survive until 8 weeks after birth. Interestingly, a third lamin A null 
mice strain, a conditional knockout, shows an identical life span to the gene trap 
model (Kim and Zheng, 2013). Furthermore, mice heterozygous for the original 
lamin A knockout develop cardiac myopathy, whereas genetrap heterozygous 
mice appear to be healthy (Kubben et al., 2011; Wolf et al., 2008)  These results 
indicate that the truncated lamin A Δ8-11 has retained at least some of the 
functions of full length lamin A, and that the truncated form even can be 
harmful (Jahn et al., 2012). This shows that even a successful disruption of an IF 
gene can be unsuccessful in deleting the protein function due to the structural 
features of IFs.   
2.4.1.2 Knock-in approaches  
Deleting a protein does not always give much information about the functions of 
that particular protein. In these situations, the expression of a mutated or 
truncated version of the protein, instead of the normal form, can give greater 
insights into its roles. In knock-in mice, a normal copy of the gene of interest is 
exchanged to a mutated form using recombinant DNA technology. 
This strategy has been employed to study disease-causing IF mutations as well as 
the function of certain regions of IFs in vivo. The laminopathies are the most 
studied IF-caused diseases, and several mice models for various laminopathies 
have been created (Zhang et al., 2013). These models have given new insight into 
the phenotypes of many laminopathies, though some mouse models do not 
phenocopy the human disease caused by the corresponding mutation. For 
example, the mouse overexpressing lamin A M371K develops acute cardiac 
damage that is much more severe than the corresponding human Emery-
Dreifuss muscular dystrophy (EDMD), where patients develop cardiac damage 
gradually (Wang et al., 2006). 
The deletion of vimentin did not reveal much about the molecular functions of 
this abundant protein (Colucci-Guyon et al., 1994). As vimentin is heavily 
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phosphorylated with numerous identified but so far sparsely studied 
phosphorylation sites, a different strategy to gain insight into both the functions 
of vimentin and the role of phosphorylation was employed. Matsuyama et al 
(2013) created mice expressing vimentin where all the sites known to be 
phosphorylated during mitosis were mutated to mimic an un-phosphorylated 
state  (Matsuyama et al., 2013). In the lens (the only organ studied this far) of 
these mice the cells fail to undergo proper cytokinesis at the end of mitosis. This 
leads to an accumulation of bi-nucleated cells, aneuploid cells and the 
development of cataract. This underscores the importance of phosphorylation 
for breakdown of IFs during mitosis (Izawa and Inagaki, 2006; Sahlgren et al., 
2001). 
The knockout of lamin B1 and lamin B2 generated the question of how and if 
these B-type lamins have overlapping functions. The approach to investigate this 
issue was to develop knock-in mice which express lamin B1 in the lamin B2 
locus and mice that express lamin B2 in lamin B1 locus (Lee et al., 2014). These 
mice made it possible to prove that lamin B1 and B2 cannot functionally be 
exchanged for each other during brain development, although the extra amount 
of one B-type lamin somewhat reduced the phenotypes of lack of the other. The 
strategy to exchange one of the lamin B genes for the other offers a solution for 
the ever present problem regarding compensatory effects of other IFs in lack of 
function approaches. A similar strategy has also been used to create mice lacking 
all type II keratins, and thus all keratin filaments (Bär et al., 2014). In reality it is 
of course not possible to exchange all the different IFs for just one, although it 
would be an interesting approach, but for some of the closely related genes this 
strategy can offer new insights. 
As discussed earlier, the devastating accelerated aging disease HGPS is caused by 
a mutation of lamin A that gives rise to a truncated protein form named 
progerin (Eriksson et al., 2003). To study the mechanisms behind this disease 
several mouse models have been created (Jung et al., 2014; Osorio et al., 2011; 
Varga et al., 2006; Yang et al., 2005); reviewed in (Zhang et al., 2013). The 
different approaches used to create mice expressing progerin, ranging from 
introduction of point mutations in the mouse LMNA gene to knock-in of the 
mutated human form, have given rise to surprisingly different phenotypes 
(Zhang et al., 2013). The phenotype dispersion cannot be easily explained, but 
most probably it arises from the different strategies and vectors used. Although 
all the progerin mice show some resemblance with the human patients, they are 
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not a perfect phenocopy of the human disease. Nevertheless, these mice are still 
useful for aging studies.  
2.4.1.3 Fluorescence to study IF gene activity and protein dynamics 
One of the challenges in visualizing IFs in tissue is the cumbersome labelling 
processes relying on antibodies. To be able to detect IFs in tissue sections, as well 
as in live mice, fluorescent proteins have been utilized.  
There are several different mice strains with nestin promoter driven GFP-
expression. These mice are often, perhaps misleading, referred to as nestin-GFP 
mice. The original strain expresses GFP under the nestin promoter and the 
enhancers from the second intron of the rat nestin gene (Yamaguchi et al., 2000). 
In another strain a similar approach was utilized, but a longer part of the 
promoter was used (Mignone et al., 2004). Furthermore, a mouse which 
expresses GFP under the control of a hsp68 promoter and the nestin second 
inton enhancer element has been generated (Kawaguchi et al., 2001). The mice 
developed by Kawaguchi et al (2001) were later further developed when the GFP 
was exchanged for dVenus, a fluorescent protein with short half-life (Sunabori et 
al., 2008). The fast degradation of dVenus made it possible to follow the activity 
of the nestin enhancer element in real-time during the different phases of the cell 
cycle (Sunabori et al., 2008). Yet a different strategy was employed to create mice 
expressing GFP under the second inton enhancer and thymidine kinase 
promoter (Walker et al., 2011). The expression patterns of GFP vary between the 
different strains (Walker et al., 2011; Yamaguchi, 2005), and some are reported 
to express GFP in cells where no nestin could be detected at protein level 
(Mignone et al., 2004).  
Although mice expressing GFP under the nestin promoter and/or enhancers do 
not give any information about nestin protein levels, these mice give invaluable 
information about where and when the nestin gene is expressed. These mice 
have also become a valuable tool for identifying nestin positive cells, as well as 
processes relying on these cells. Apart from identifying nestin positive cells in the 
central nervous system (Kawaguchi et al., 2001; Mignone et al., 2004; Walker et 
al., 2011; Yamaguchi et al., 2000), these mice have also been used for 
identification and isolation of satellite cells from muscle (Day et al., 2007), and to 
identify and follow stem cells in various tissues (Jiang et al., 2014; Li et al., 2003). 
More recently the nestin GFP mice have been crossed with nude mice (Amoh et 
al., 2005) and used for live imaging of angiogenesis in tumour bearing mice (Aki 
et al., 2014).  
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Apart from the mice expressing fluorescent proteins under direct control of the 
nestin promoter and enhancer elements, mice that express tamoxifen inducible 
cre-recombinase under the nestin promoter have been created (Lagace et al., 
2007). These mice have been crossed with mice having fluorescent proteins with 
loxP-sites to create mice where nestin positive cells can be induced to become 
fluorescent (Chow et al., 2015; Lagace et al., 2007). This setup allows for fate 
tracking of certain cells as well as identification of nestin positive cells in adults. 
Lately, mice that can be used in a more direct way to study IF dynamics have 
been created. The keratin 8-YFP mice carry an YFP sequence inserted in frame 
with the endogenous keratin 8 gene, an approach which gives rise to a keratin 8-
YFP fusion protein expressed and regulated as the endogenous keratin 8 
(Schwarz et al., 2015). In contrast to the nestin-GFP mice the keratin 8-YFP mice 
do not only give information about protein expression, but can also be utilized 
for live imaging of keratin dynamics. The advantages of the keratin 8-YFP mice 
compared to classical staining methods are obvious, and the mouse model has 
already provided enhanced knowledge about the intercellular arrangements and 
dynamics of keratin 8 (Schwarz et al., 2015). 
2.4.2 Invertebrate models to study IFs 
Although the studies of genetically engineered mice have given many valuable 
insights into the functions of IFs, mice have several drawbacks as animal models. 
Most apparent are the cost and long generation turnover. As IFs are evolutionary 
conserved and present in all animals, invertebrates can be used to study IFs. 
Most commonly the nematode Caenorhabditis elegans (C. elegans) has been 
employed.  
C. elegans has 11 genes coding for IFs, four of which are essential for 
development and survival (Karabinos et al., 2001). Given that the cytoplasmic 
IFs in C. elegans are more closely related to the nuclear lamins than to 
mammalian cytoplasmic IFs, insights from the nematode cytoplasmic IFs cannot 
be directly translated to human findings. Nevertheless, the nematode offers a 
splendid platform for studying general aspects of IFs. Furthermore, the 
nematode lamin has direct human counterparts, and corresponding mutations 
have been proven to be a valuable tool for laminopathy research (Bank et al., 
2012).     
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The fruit fly, Drosophila melanogaster (D. melanogaster) belongs to the 
arthropods, animals with exoskeletons, a phylum that has long been considered 
to lack cytoplasmic IFs (Bartnik and Weber, 1989). D. melanogaster has two 
lamins resembling the human A- and B-type lamins, lamin C and lamin Dm0, 
respectively. Knockout of lamin C in Drosophila, as well as expression of mutant 
human lamin, has successfully been employed for studies of lamin 
function (Lyakhovetsky and Gruenbaum, 2014). Knockout of lamin C, the 
Drosophila A-type lamin, leads to lethality in the larval or pupal stages of 
development (Schulze et al., 2005; Schulze et al., 2009; Uchino et al., 2013). More 
specifically, the lack of lamin C affects muscle function by causing 
disorganization of the tendon nuclei and faulty MTJs (Uchino et al., 2013). This 
finding is interesting as it offers a new explanation for the mechanisms causing 
the muscle laminopathies. Unfortunately, tendon cells have not yet been 
investigated in human laminopathy patients.    
Recently, a Drosophila model expressing the human keratins 5 and 14 has been 
established (Bohnekamp et al., 2015). The authors also introduce an EBS causing 
mutant to the flies. While the wild type keratins seemingly do not affect the flies, 
the mutant keratins give rise to a phenotype surprisingly similar to the human 
disease with blistering of the wings. This research not only shows that the 
expression of human cytoplasmic IFs in flies is possible, but also that disease-
causing mutations can be studied in this system. 
In summary, these examples prove that invertebrates can be utilized for IF-
research, but also that, like mice, they have certain shortcomings. Most of the 
problems with invertebrate models for human IF-research stems from the 
evolutional distance, but for basic research invertebrates remain an interesting 
alternative.    
2.5 Cdk5 – an IF interacting kinase 
Cdk5 belongs to the class of cyclin dependent kinases, but unlike other cyclin 
dependent kinases Cdk5 is not regulated in a cell cycle dependent manner, and 
until recently it was thought to be regulated only by non-cyclin proteins (Arif, 
2012; Contreras-Vallejos et al., 2012; Dhariwala and Rajadhyaksha, 2008). The 
most studied Cdk5 activators are the non-cyclin proteins p35 and p39 and their 
cleavage products p25 and p29. In addition, Cdk5 has been shown to interact 
with cyclin D, cyclin E, cyclin G1 and cyclin I; reviewed in (Arif, 2012). The 
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different activators can both influence Cdk5 localization and target range 
(Brinkkoetter et al., 2009; Hagmann et al., 2015). 
 The most well-known Cdk5 activators, p35 and p39, are myristoylated, a PTM 
that targets them, and the Cdk5 activity they induce, to the plasma membrane 
(Patrick et al., 1999). When p35 is cleaved to p25 by calpains the myristoylation 
is lost, leading to de-attachment from the membrane and a localization shift in 
the Cdk5 activity. The cleavage of p35 does not only permit a shift in localization; 
p25 is a more potent Cdk5 activator as it has a substantially longer half-life due 
to being protected from proteasomal degradation (Patrick et al., 1998). The idea 
that localization of the different activators drives Cdk5 activity to certain parts of 
the cell has recently been brought to attention (Asada et al., 2012; Hagmann et al., 
2015). With the use of p35-/-, cyclin I-/- and p35-/- cyclin I-/- mice it has been 
demonstrated that cyclin I sequesters Cdk5 in the nucleus, whereas p35 drives a 
cytoplasmic localization (Hagmann et al., 2015). Interestingly, not only the 
activators but also their Cdk5-induced phosphorylation regulate Cdk5 
localization, at least in the case of p35 and p39 (Asada et al., 2012). Furthermore, 
the localization of Cdk5 is cell type-dependent, as the different Cdk5 activators 
have distinct expression patterns in different tissues.   
Cdk5 was initially thought to harbour kinase activity only in the brain and in 
nervous tissue (Tsai et al., 1993). Its presence is essential for brain development, 
as disruption of the Cdk5-gene leads to embryonic or early post-natal death due 
to under-development of the brain (Ohshima et al., 1996). Deregulated Cdk5 has 
also been linked to several neurodegenerative diseases such as Alzheimer's, 
Parkinson's and Huntington's diseases; reviewed in (Cheung and Ip, 2012). The 
deregulated neuronal Cdk5 activity is associated with production of protein 
inclusions; in Alzheimer's, for example, the excess phosphorylation of Tau and 
NFs by Cdk5 drives the formation of neurofibrillary tangles (Shukla et al., 2012). 
Nevertheless, more recent studies have detected Cdk5 activity and showed 
functions for Cdk5 outside the nervous system in tissues such as kidney, 
pancreas and muscle; reviewed in (Arif, 2012; Contreras-Vallejos et al., 2012; 
Rosales and Lee, 2006). Cdk5 has received attention in conjugation to diabetes, 
as it regulates both insulin secretion (Lee et al., 2008) and glucose uptake (Lalioti 
et al., 2009), as well as in cancers, as it has functions in processes such as 
migration and angiogenesis; reviewed in (Liebl et al., 2011), but the non-
neuronal functions of Cdk5 have remained less studied than the neuronal 
functions. In models of muscle differentiation Cdk5 activity has been shown to 
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be important for regulation of differentiation, both in mouse and rat cell-lines as 
well as in Xenopus embryos (Lazaro et al., 1997; Philpott et al., 1997). More 
specifically p25-driven Cdk5 activity has been determined as a critical factor for 
the onset of differentiation (de Thonel et al., 2010).  
The relationship between IFs and Cdk5 is complex; NFs (Pant et al., 1997; 
Sharma et al., 1998), vimentin (Lee et al., 2012), nestin (Sahlgren et al., 2003) and 
lamin (Chang et al., 2011) have all been identified as Cdk5 substrates. As noted 
above, at least nestin also works as a scaffold for Cdk5 and regulates its 
localization as well as its activity by regulating p35 turn-over (Figure 5) 
(Sahlgren et al., 2003; Sahlgren et al., 2006). The interplay between Cdk5 and 
nestin has been shown to regulate myogenic differentiation in vitro (Pallari et al., 
2011; Sahlgren et al., 2003). The nestin-driven regulation of Cdk5 also underlies 
the organisation of NMJ in vivo, as mice with down-regulated nestin show 
clustering of NMJs, underscoring the role of nestin as a Cdk5 scaffold (Yang et 
al., 2011). 
 
Figure 5. Nestin as a regulator of Cdk5 activity and localization. In the 
cytoplasm, nestin forms a scaffold for p35 and Cdk5. This scaffold prevents the 
cleavage of p35 to p25 and the transport of p25/Cdk5 into the nucleus.   
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2.6 Satellite cells and muscle regeneration 
The long multinucleated cells of the muscle, the muscle fibers, do not divide, but 
yet the number of nuclei in a fiber can increase and the fibers can grow in size 
(and when injured, re-grow). These processes depend on stem cells that reside 
outside of the muscle fiber.     
These satellite cells are the primary stem cells of muscle; under normal 
conditions they reside in a quiescent state under the basal lamina of myofibers. 
The satellite cells are identified by their expression of certain marker proteins: 
mostly used is pax7, a transcription factor expressed by quiescent and early 
activated satellite cells (Yin et al., 2013). Although mostly mitotically inactive 
under normal conditions, satellite cells can divide in a symmetrical fashion, 
giving rise to two stem cells, to keep the stem cell population size intact. 
Activated satellite cells can also divide asymmetrically, giving rise to one stem 
cell and one cell committed to differentiation (Yin et al., 2013).  
Muscle regeneration after injury is a distinct process, although it resembles and 
shares some mechanisms with developmental muscle growth. The first 
regenerative processes start immediately after a muscle injury: the damaged 
myofibers undergo necrosis and an inflammatory response starts. Neutrophils 
and macrophages invade the injury site and take part in the clearing process; the 
later macrophages also secrete factors that stimulate myoblast proliferation and 
differentiation; reviewed in (Ciciliot and Schiaffino, 2010; Yin et al., 2013). Soon 
after an injury the satellite cells become activated and start proliferating. The 
activation of satellite cells is a complex process regulated by numerous secreted 
factors such as growth factors, interleukins and nitric oxide; reviewed in (Chargé 
and Rudnicki, 2004; Yin et al., 2013). The satellite cells differentiate and fuse 
with existing myotubes to rebuild the muscle (Figure 6). The last step of the 
regeneration process is to re-obtain muscle homeostasis, this step includes re-
building of NMJs and MTJs as well as re-growth of blood vessels (Ciciliot and 
Schiaffino, 2010).  
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Figure 6. Muscle regeneration. Under normal conditions (1) the myofibers are 
resting and the satellite cells reside under the basal lamina in a quiescent state. 
Upon myotrauma (2) the satellite cells get activated and start to proliferate. Some 
of the new cells will become new quiescent stem cells (self-renewal), whereas most 
will migrate to the injured muscle fiber (3), undergo differentiation and fuse either 
with an existing fiber or with each other to form a new fiber (4). The regenerating 
myofiber (5) is characterised by centrally located nuclei, but over time the nuclei 
will migrate to the periphery of the fiber as the myofiber enters a resting state (1). 
Figure adapted from  (Hawke and Garry, 2001). 
2.6.1 Models to study muscle differentiation and regeneration 
The most commonly used cell line to study muscle differentiation in vitro is the 
C2C12 line. These cells originate from an adult, dystrophic, female mouse and 
readily form myotubes in culture in response to high confluency and serum 
withdrawal  (Yaffe and Saxel, 1977). Although, or maybe because, this cell line 
has been used for several decades it has some shortcomings. To gain a more 
physiologically relevant cell culture model, primary myoblasts can be isolated 
from mouse muscle. There are many, slightly different, protocols for primary 
myoblast isolation, but they are all based on physical disruption and enzymatic 
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digestion of whole muscles, followed by culture of the cells under conditions 
promoting myoblast survival. The downside with primary myoblast culture, 
apart from the need of animals and the workload, is that they are, to a greater or 
lesser extent, contaminated by other cell types such as adipocytes and fibroblasts. 
To achieve pure satellite cell cultures, cell sorting of muscles digests can be used. 
Commonly the nestin-GFP and Pax7-GFP mice strains, as well as sequential 
antibody labelling of satellite cell specific proteins, have been used for this 
(Bosnakovski et al., 2008; Day et al., 2007; Pasut et al., 2012). Another method to 
achieve pure satellite cell cultures is the isolation of intact myofibers with their 
associated satellite cells; overviewed in (Keire et al., 2013).   
Multiple injury models have been established to study the regeneration of 
injured muscle in vivo. To mimic common sport-type injuries, physical force 
such as blunt impact, crush, tear or local incisions have been used; reviewed in 
(Carlson, 2008; Souza and Gottfried, 2013). In addition, models that take 
advantage of myotoxins such as snake venoms and local anaesthetics are often 
used (Carlson, 2008). These injuries are cleaner than the physically induced 
injuries, but have the disadvantage of being less clinically relevant. The model 
system to be used has to be chosen depending on which of the regeneration 
processes one intends to study.   
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3 Aims 
The aim of this work was to study IFs at the molecular, cellular and organism 
level to gain more basic knowledge of these proteins. Lately the IFs have emerged 
as important regulators of cell signalling events. This has led to a shift in the IF-
research from structural properties to functional aspects of IFs. When this work 
began, the phosphorylation of lamins had mainly been studied in the context of 
mitotic reorganisation of the lamina (Dessev et al., 1990; Dessev et al., 1991; 
Heald and McKeon, 1990; Peter et al., 1990). As phosphorylation had been 
shown to influence many IFs in more than just structural manners, we wanted to 
explore the effects of lamin A phosphorylation outside mitosis and investigate 
how phosphorylation regulates the localization and dynamics of lamin A.  
Nestin had previously been identified in many cell types and tissues and there 
were limited studies on nestin in myogenic differentiation. The role and function 
of nestin in vivo, however, was unknown. As the nestin-/- mice became available, 
we wanted to expand our previous work, where nestin had been identified to 
influence muscle cell differentiation in vitro and to be expressed in muscle 
regeneration in vivo (Pallari et al., 2011; Sahlgren et al., 2003; Vaittinen et al., 
2001). We aimed at studying how the absence of nestin influences cell and body 
homeostasis, with emphasis on the functions of nestin during muscle 
regeneration and homeostasis 
The absence of cytoplasmic IFs in arthropods has long baffled the IF-field. At the 
same time the need for new model organisms to study IFs has become apparent, 
both for ethical and economic reasons, and in order to avoid the risk of 
compensation by a related IF. We wanted to tackle both of these questions by 
exploring the possibility to express a human cytoplasmic IF in Drosophila 
melanogaster.      
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4 Materials and Methods 
More detailed information on the materials and methods used can be found in 
the original publications and manuscripts. 
4.1 Standard methods and Cell lines used 
A summary of standard methods and cell lines that I have used in the indicated 
manuscripts is found bellow. 
 
HeLa human cervical cancer cell line (I) 
ST15A rat CNS progenitor cell line (unpublished) (Frederiksen et al., 1988) 
Primary mouse myoblasts and satellite cells (II) 
Schneider 2 (S2) Drosophila cells (III) 
 
Cell culture (I, II, III, unpublished) 
Microscopy (I, II, III) 
Site-directed mutagenesis (I) 
Western blot (I, II, III, unpublished) 
Induction of muscle injury (II) 
 
4.2 GFP-tagged lamin constructs 
The full-length human prelamin A cDNA cloned into pEGFP-C1 was cloned in 
Dr. Robert Goldman’s lab (Moir et al., 2000). When expressed in cells, this 
plasmid gives rise to prelamin A with GFP fused to the N-terminal end, the 
protein undergoes the same posttranslational processing as endogenous pre-
lamin A. Mutations in the original plasmid were induced using QuikChange 
site-directed mutagenesis kit (Stratagene). In order to create plasmids which 
mimic an un-phosporylated state, the targeted serine residues were changed to 
alanine. Alanine has a non-reactive, neutral side chain and is therefore ideal to 
use for a non-phosphorylated substitute. Aspartate was used to mimic 
constitutive phosphorylation; aspartate has a negatively charged side chain that 
mimics the charge of a phosphate group.   
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4.3 Primary myoblast and myofiber cultures 
Primary myoblasts were isolated from adult mice and from pups at postnatal day 
3 as previously described (Danoviz and Yablonka-Reuveni, 2012). This protocol 
gives a good yield of myogenic precursor cells, but the cultures are frequently 
contaminated with other cell types, like fibroblasts. These cells do not affect the 
analysis of molecules specific to the myogenic linage; they do, however, influence 
the non-myogenic transcriptome, which can be problematic in certain analyses. 
As the yield from this protocol is very high, it was used for western blot analyses 
of myoblast differentiation as well as for molecular studies of Cdk5. 
 
To obtain cleaner satellite cell cultures, intact myofibers from adult mice were 
isolated as previously described (Keire et al., 2013). This method results in whole 
live myofibers cultured floating in media. Activated satellite cells then migrate 
out from the fibers and start proliferating and differentiating. This method gives 
rise to very clean cultures, but the yield is low. The myofiber cultures were used 
for microscopic imaging of satellite cell numbers and their differentiation. These 
kinds of analyses give very specific data in contrast to the bulk data acquired 
from myoblast cultures.  
 
4.4 Additional methods 
To identify lamin residues phosphorylated by Cdk5, an IF-preparation done 
according to (Sahlgren et al., 2001) was phosphorylated in vitro with 
recombinant Cdk5/p25 complex as described previously (Lindqvist et al., 2015). 
The phosphorylated samples were separated by SDS-PAGE and the bands 
corresponding to lamins were cut out and analyzed by mass-spectrometry as in 
Kochin et al., (2014).  
 
In order to investigate the influence of lamin A on p35 localization, ST15A cells 
transfected with p35 and GFP or GFP-lamin A were fractionated. The 
fractionation protocol from Markiewicz et al., (2005) allows for separation of the 
nuclei from the cytoplasm; the nuclei are then further extracted with buffers 
containing increasing amounts of salt for separation into low salt soluble, high 
salt soluble and insoluble fractions.  
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Cycloheximide (CHX) is an inhibitor of protein synthesis which can be utilized 
for determination of protein degradation rate. ST15A cells were transfected with 
p35 and GFP or GFP-lamin A. 15 to 20 h after the transfection the cells were 
treated with 30µg/ml CHX, then lysed after 1 h and 2 h, and p35 content was 
analysed using western blotting.  
 
To determine Cdk5 activity ST15A cells were transfected with GFP-lamin A or 
GFP, lysed, and then Cdk5 was immunoprecipitated and used to phosphorylate 
histone in presence of 32P-ATP as described in (Lindqvist et al., 2015). The 
amount of incorporated ATP was analyzed with Phosphoimager. 
 
To analyse cell death ST15A cells transfected with GFP-lamin A or GFP were re-
suspended in propidium iodine buffer (40 mM Na-citrate, 0.3% Triton-X 100, 
50µM propidium iodine) and analysed with LSRII flow cytometer (BD 
Biosciences). Each sample was run in triplicate. The fraction of sub-G1 events 
(nuclear fragmentation) was gated as a measure of apoptotic cell death.  
 
Serum testosterone was determined from serum collected from 3-month-old 
nestin-/- and wild type male mice by cardiac punctuation. The serum was 
analysed with liquid chromatography–tandem mass spectrometry at the 
Department of Pharmacy, University of Eastern Finland. The detection limit for 
testosterone was 0.08 nM. 
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5 Results and Discussion 
5.1 Phosphorylation determines lamin A/C localization and 
mobility (I) 
Lamin A/C has previously been shown to be heavily phosphorylated, and many 
of the phosphorylation sites have been identified (Simon and Wilson, 2013). Yet 
few of the identified sites have been studied in detail, as most of the 
identification has been in high-throughput mass-spectrometry analyses. 
Furthermore, many sites have been detected in mitotic or mixed cell populations, 
leaving the role of steady-state interphase phosphorylation of lamin A/C open. 
To address these questions we performed a study combining mass-spectrometry 
results from interphase cells with site directed mutagenesis and detailed imaging 
based studies.   
We identified 20 phosphorylation sites from interphase HeLa-cells. (Figure 7, I 
Table 1). In order to study how the phosphorylation of these sites affects primal 
lamin properties such as mobility and localization, GFP-tagged lamin constructs 
were generated. By site directed mutagenesis we introduced mutations of the 
most occupied phosphorylation sites that we identified. To mimic the un-
phosphorylated state serine was mutated to alanine, and to mimic 
phosphorylation mutation of serine to aspartic acid was utilised.  
 
Figure 7. Lamin A/C phosphorylation sites. Summary of the phosphorylation 
sites identified in (I). Figure from (Torvaldson et al., 2015). 
To determine the effect of the mutations, which are indicative of the effect of  
phosphorylation, on lamin A localization, mobility and solubility, confocal 
microscopy in conjugation with triton-X extraction, and fluorescence recovery 
after photobleaching (FRAP) were used. In addition fluorescence correlation 
spectroscopy (FCS) was utilised. The results from these experiments are 
summarized in Tables 3-5 (I Figures 2-7). The previously identified mitotic 
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phosphorylation sites S22 and S392 (Dessev et al., 1990; Dessev et al., 1991; 
Heald and McKeon, 1990; Peter et al., 1990) clearly affect lamin A also in 
interphase. Our results indicate that S22 is dominant over S392, but that 
phosphorylation of both these sites work together to regulate lamin A properties.  
The S22D, S392D doublemutation was further combined with a S628D mutation, 
to create a triple phosphomimetic construct. This construct unexpectedly 
localizes to the cytoplasm in part of the cells (I Figure 8). This suggests that 
sequential phosphorylation could lead to the exclusion of lamin A from the 
nucleus. In the light of the recently discovered cytoplasmic function of lamin B2 
(Yoon et al., 2012),  it is tempting to speculate about a similar role for 
cytoplasmic lamin A, but to date there is no in vivo evidence for triple 
phosphorylation of lamin A nor a confirmed cytoplasmic role has been shown. 
S628 is also interesting because this residue is located in the part missing from 
progerin, the pathological form of lamin A expressed in Hutchinson-Gilford 
progeria syndrome (Eriksson et al., 2003). The loss of the S628 phosphorylation, 
with yet unknown functions, offers a further explanation for the toxicity of 
progerin.  
Table 3 Effect of mutations on lamin A localization  
Site S to A 
(phosphodeficient) 
S to D 
(phosphomimetic) 
S12 no effect no effect 
S22 no effect nucleoplasm 
S390 lamina no effect 
S392 lamina nucleoplasm 
S404 S407 no effect nucleoplasm 
S423 no effect no effect 
S628 no effect no effect 
S22, S392 lamina nucleoplasm 
S22D, S392A - nucleoplasm 
S22A, S392D - no effect 
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Table 4 Effect of mutations on lamin A mobility 
Site Lamina Nucleoplasm  
S22D, S392D ++ + 
S22D, S392A + + 
S22A, S392A -- no effect 
S22A, S392D - + 
 
Table 5 Effect of mutations on lamin A solubility 
Site Lamina  Nucleoplasm  
S22D, S392D + + 
S22D, S392A + + 
S22A, S392A - - 
S22A, S392D - - 
 
5.2 The physiological relevance of lamin A/C 
phosphorylation  
With very few exceptions, the laminopathy causing mutations does not affect 
known phosphorylation sites. The fact that the lamin A/C phosphorylation sites 
show high evolutionary conservation (I, Figure 1) reflects their low tolerance for 
mutations and can explain why the phosphorylation sites are so rarely mutated. 
Any mutation affecting these sites would probably be lethal at an early 
developmental stage due to a dominant negative effect.   
The only reported lamin mutation directly affecting an identified 
phosphorylation site is a heterozygous lamin A S22L mutation (Pethig et al., 
2005). The patient with this mutation suffered from dilated cardiomyopathy 
requiring a heart transplant. As there is no detailed description of this case, it is 
difficult to know what effects such a mutation has on the cellular level. 
Proline 4, which resides between T3 and S5, both of which were identified in our 
study of interphase phosphorylation (I), has been reported to be mutated in a 
mild progeria like syndrome (Garg et al., 2009; Guo et al., 2014). The mutation 
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of this proline will most likely influence the phosphorylation of the surrounding 
amino acids as the proline is part of a SP-motif.   
Although few cases of direct mutations of lamin A/C phosphorylation sites have 
been reported in laminopathies, there are indications that phosphorylation is 
indirectly affected by several mutations. In EDMD, the level of N-terminal lamin 
A/C phosphorylation is decreased in muscle cells, but not in fibroblasts. The 
exact site for this phosphorylation has, however, not been determined (Cenni et 
al., 2005). In another study, the phosphorylation of S458 in patients with lamin A 
mutation-associated myopathies was investigated (Mitsuhashi et al., 2010). The 
authors found that S458 was specifically phosphorylated in cells from myopathy 
patients with lamin A/C Ig-domain mutations, but not in cells from patients 
with other myopathies or mutations in other parts of lamin A/C. Furthermore, 
Akt1 was shown to specifically phosphorylate S458 in mutated, but not in wild 
type lamin A. This specific phosphorylation could be due to the Ig-fold mutation, 
which may open up the lamin structure and expose the otherwise hidden S458 
(Mitsuhashi et al., 2010).  In contrast, we identified the phosphorylation of S458 
from interphase HeLa-cells (Kochin et al., 2014), which would indicate that S458 
also can be phosphorylated in wild type lamin A/C, and that this 
phosphorylation possibly has a non-pathological function. Although the 
phosphorylation of specific sites is altered in disease, the effect of this PTM 
change is difficult to distinguish from the effect of the disease-causing mutation.  
Lamin A/C interacts with numerous signalling molecules (Simon and Wilson, 
2013). Even though we did not investigate the effects of phosphorylation on any 
of these interactions, it will most likely affect the formation of contacts. For 
example the binding of Lap2α  has been mapped to residues 319-566 on lamin A 
(Dechat et al., 2000), a region where we identified numerous phosphorylation 
sites. Furthermore, the interaction between Lap2α and lamin A/C takes place in 
the nucleoplasm, and is thus dependent on lamin A/C localization, which in turn 
is dependent on phosphorylation. As the cell-cycle regulatory function of pRb   is 
influenced by the lamin A/C and Lap2α binding, phosphorylation of lamin A/C 
can have consequences for cell-cycle progression.  
The specific phosphorylation of lamin A/C could, thus, have many different 
effects: it affects protein localization and mobility, it could affect protein 
structure and accessibility of buried amino acid residues, and it could affect 
protein-protein interactions and downstream signalling. We propose a model 
where extracellular factors, such as stress-signals or substrate stiffness, act 
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through kinases and phosphatases to induce changes in lamin A dynamics. The 
lamin A dynamics in turn affect the interactions and functions of lamin A 
resulting in signalling output, such as altered transcription or cell motility 
(Figure 8) (Torvaldson et al., 2015). Our study, as well as previous work, has 
concentrated on the mechanical functions of lamin A/C phosphorylation, while 
the signalling induced by this PTM remains little studied. Future studies 
emphasizing the physiological functions of lamin A/C phosphorylation will have 
a great impact on our understanding of the many diverse roles these proteins 
have.  
 
Figure 8. Lamin A/C phosphorylation as a signalling mediator. Information 
received from the environment influences lamin A/C localization and 
conformation. This, in turn, will influence lamin A/C functions and interactions, 
and in the end the cellular response to the stimuli. Kinases and phosphatases 
determine the lamin A/C phosphorylation status, which is the basis for lamin 
localization, conformation, function and interactions. Image from (Torvaldson et 
al., 2015). 
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5.3 Cdk5 phosphorylates lamin A/C (unpublished) 
It has previously been reported that Cdk5 can phosphorylate lamins during 
neurotoxic stress (Chang et al., 2011). To confirm these findings, we used an in 
vitro phosphorylation strategy. Isolated IF-preparation from rat ST15A-cells was 
phosphorylated with recombinant Cdk5/p25 complex in vitro. The results clearly 
show a specific phosphorylation of the lamins (Figure 9). To investigate the 
nature of this phosphorylation the samples were analysed with mass-
spectrometry (Figure 9). The analyses confirmed that lamin A/C indeed is 
phosphorylated by Cdk5. Two highly phosphorylated Cdk5-dependent sites 
were identified: T19 and S22, furthermore phosphorylation of S212, S390, S392 
and S637 were observed at low rates. In the same sample phosphorylation of 
lamin B1, T5 was detected too, showing that B-type lamins also can be 
phosphorylated by Cdk5. 
 
Figure 9. Lamin A is a Cdk5 substrate in vitro. A, The intermediate filament fraction 
was isolated from ST15A cells and phosphorylated in vitro with recombinant 
Cdk5/p25-complex in presence of 32p-ATP. The amount of incorporated ATP was 
analyzed with phosphorimager. B, The lamin bands were extracted from the gel and 
analyzed with mass-spectrometry to identify phospho-peptides. Two lamin A sites were 
found to be specifically phosphorylated in the Cdk5 treated samples, T19 and S22.  
As previous studies have showed that the IF nestin interacts with Cdk5 and the 
Cdk5-activator p35, targeting Cdk5 activity to the insoluble cellular fraction 
(Sahlgren et al., 2006), we wanted to find out if Cdk5 regulation is a common IF 
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feature. To study this we used over-expression of lamin A in the ST15A cell-line, 
in combination with a cell fractionation protocol, where the nuclear fraction is 
extracted with buffers with increasing concentrations of salt to gain soluble and 
less soluble nuclear fractions (Markiewicz et al., 2005). Using this protocol, we 
show that lamin A sequesters p35 into the nucleus, and further to the insoluble 
nuclear fraction (Figure 10 A). This would indicate that insoluble lamin A acts as 
a scaffold for p35 in the nuclear lamina.  
To investigate if the localisation of p35 to the insoluble nuclear fraction can 
protect p35 from degradation, we examined the stability of p35 using the protein 
synthesis inhibitor cycloheximide. By inhibiting protein synthesis, and then 
following the degradation of proteins, it is possible to estimate the protein turn-
over rate. In the presence of over-expressed lamin A, p35 is degraded at a slower 
pace than in mock transfected cells (Figure 10 B). These results indicate that 
over-expression of lamin A both changes the localisation and stabilizes p35, 
possibly by protecting p35 from proteasomal degradation.  
Next we investigated if the elevated p35 levels affect Cdk5 activity. To do this, 
ST15A cells over-expressing GFP-lamin A or GFP alone were used for a Cdk5 
activity assay. As expected, the lamin A over-expression induced p35 
stabilisation, which clearly increases Cdk5 activity (Figure 10 C). The 
physiological importance of the lamin A over-expression was investigated in a 
stress situation. ST15A cells were treated with 100µM H2O2 for 6 h to induce 
oxidative stress; the cells were then subjected to propidium iodine staining and 
FACS-analysis. The results show that cells over-expressing lamin A undergo 
apoptosis at a higher rate than control cells, as more cells have fragmented nuclei 
(cells in sub-G1 phase) (Figure 10 D). This indicates that the lamin A induced 
Cdk5 activity has pro-apoptotic function. To prove that the increased apoptosis 
is due to Cdk5 activity further experiments where Cdk5 activity is inhibited by 
use of kinase dead Cdk5 or with Cdk5 down-regulation will be needed. 
Previously, nestin too has been reported to stabilise p35 and sequester it in the 
cytoplasm in ST15A cells, and to protect the cells from oxidative stress (Sahlgren 
et al., 2006). When our results are combined with the previous results, it is clear 
that both a cytoplasmic and a nuclear IF have the ability to stabilize and scaffold 
p35, indicating that the balance between these IFs would be crucial for the 
amount and localization of available p35 in the cell. As lamin A and nestin 
turned out to have the opposite effects in terms of cell survival, it is also clear 
that the sequestration of p35 has a physiological role. In addition to nestin and 
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lamin A, also NFs and vimentin are phosphorylated by Cdk5. It would therefore 
be interesting to look into which roles these IFs have on Cdk5 activity and 
localization. As previously noted, the different IFs are expressed in a highly 
regulated manner in different cell types and during differentiation.Cdk5 activity 
also differs in different cellular compartments and at different rates during the 
same processes. It is thus very tempting to speculate that the expression-profile 
of IFs could regulate localisation of Cdk5 activity in cells.  
 
Figure 10. Lamin A influences p35 localisation and stability. ST15A cells were 
transfected with GFP or GFP-lamin A and, in addition, p35 (A, B).  A, The cells 
subjected to cell fractionation. The cells over-expressing lamin A have a higher p35 
content, and furthermore more p35 in the nuclear and especially the insoluble 
nuclear fraction. This suggests that lamin A confines part of the p35-pool to the 
lamina. B, The cells were treated with the protein synthesis inhibitor cycloheximide 
for indicated time, lysed and subjected to western blotting with indicated 
antibodies. The half-life of p35 is prolonged in the presence of lamin A; this 
indicates that lamin A protects p35 from degradation by sequestering it in the 
lamina. ST15A cells were transfected with GFP or GFP-lamin A (C, D). C, Cdk5 
was immunoprecipitated from the cells and used to phosphorylate histone in 
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presence of 32P-ATP. The amount of incorporated ATP was analyzed with 
phosphoimager. The results show that Cdk5 activity is increased in cells over-
expressing lamin A. D, Cells were treated with 100µM H2O2 for 6h to induce 
oxidative stress and then subjected to propidium iodine staining followed by 
flowcytometry analysis. The GFP-lamin A over-expressing cells have decreased 
survival potential as shown by an increased amount of cells in the sub-G1 fraction. 
The bars represent average ± SEM of two independent experiments. The western 
blots are representative from three independent experiments. 
5.4 Depletion of nestin has no obvious effect on muscle 
stem cell behaviour (II) 
Nestin is considered a stem cell protein, and nestin gene activity has been 
identified as a specific marker of quiescent satellite cells (Day et al., 2007). The 
down-regulation of nestin with siRNA in C2C12 myoblasts leads to  a 
remarkable increase in myogenic differentiation (Pallari et al., 2011), showing 
that nestin plays an important role in regulating the differentiation pace. To 
investigate the stem cell number and behaviour following genetic ablation of 
nestin was thus the outset for our study of the nestin-/- mice.  
In primary myoblast isolated from nestin-/- mice, no changes in differentiation 
were observed compared to corresponding wild type cultures. The protein levels 
of the Cdk5 activator p35 were, however, remarkably up-regulated in nestin-/- 
myoblast cultures (II Figure 4). This was in line with elevated Cdk5 activity as 
measured by Cdk5 assay (II Figure 4). In previous studies, we have shown that 
Cdk5 activity, and in particular p25-driven Cdk5 activity, is needed for 
differentiation of myoblasts (de Thonel et al., 2010; Pallari et al., 2011). As p35 is 
localized to the plasma membrane, whereas p25 to the cytoplasm and the 
nucleus, the elevated p35 levels in the nestin-/- myoblasts may not influence the 
Cdk5 activity in the right cellular compartment for driving differentiation, and 
hence, no difference in differentiation was observed.  
The numbers of satellite cells were assessed from myofibers fixed immediately 
after isolation and stained against pax7 (II Figure 3). The number of satellite cells 
did not differ between nestin-/- and wt myofibers, indicating that although nestin 
normally is expressed in these cells, its absence does not influence satellite cell 
numbers. To further characterize the behaviour of satellite cells, single myofibers 
were kept floating in culture for 72 hours. Under these conditions, the satellite 
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cells associated with the fibers will become activated and start to differentiate. 
This system allows for quantification of single cells expressing stem cell and 
differentiation markers, and thus gives a more clean view than myoblast cultures 
analyzed by western blotting. By staining the myofiber cultures with the satellite 
cell marker pax7 and the early differentiation marker MyoD, we found no 
significant difference in differentiation between nestin-/- satellite cells and wt 
satellite cells. This reflects the unaltered differentiation observed in the myoblast 
cultures. The divergence between these and previous results obtained from 
nestin siRNA treated C2C12 cells (Pallari et al., 2011) is not surprising, 
considering the different cell systems and the different modes of nestin depletion. 
The floating myofiber cultures reflect a more natural environment with 
signalling from the myofiber as well as from the activated satellite cell. The 
myoblast cultures are not as clean as the cell line or the myofiber cultures due to 
the isolation process, and minor changes can be masked by the presence of other 
cell types. The different modes of nestin depletion may also affect the results; 
downregulation with siRNA (Pallari et al., 2011) is not as effective as genetic 
depletion (Mohseni et al., 2011), and remaining levels of nestin can have a 
profound effect on myoblast differentiation.         
5.5 Nestin influences body composition (II) 
Although nestin is a minor IF in the adult, it could potentially influence 
developmental growth as well as tissue homeostasis; to examine this, we 
determined the body weight of a large set of mice, as well as food intake and 
spontaneous activity from a subset. Although there was no difference in activity 
or eating between the genotypes (II Supplementary Figure 1), we found that 
mice lacking nestin weigh significantly less than their wild type counterparts. 
This is true for both 3-month old male and female mice, and particularly for 15-
month-old male mice (II Figure 1, Supplementary Figure 2). Younger mice did 
not show any weight differences. This means that the nestin-/- mice do not 
accumulate weight in the same manner as wild type mice. To further investigate 
the source of the mass difference, the animals were scanned with the EcoMRI 
system. This body composition analyzer allows for the differentiation of fat and 
lean mass of live mice. The results clearly showed that the lean mass of nestin-/-
 mice was less, whereas the average fat mass was unaltered compared to wild type 
mice. II Figure 1. To confirm the decreased muscle mass in nestin-/- mice, 
muscles from the hind legs were dissected and weighed (II Figure 2). The tibilalis 
anterior (TA) and extensor digitorum longus (EDL) muscles from nestin-/- mice 
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were significantly lighter than the wild type muscles, whereas the mass of soleus 
was not changed. Although the nestin-/- muscles were lighter, the myofiber size, 
as assessed from sections of soleus and EDL muscles, does not differ. Taken 
together, these results show that nestin-/- mice have less muscle mass and that this 
phenotype is gender independent, becoming more prominent with age.  
Several other IF-knockout mice have been shown to have decreased body mass. 
Mice lacking the major muscle IF desmin weigh less than wild type mice (Wede 
et al., 2002), but given the severe myopathy and cardiopathy these mice show 
(Milner et al., 1996), the weight difference is not surprising. Mice lacking the 
nestin-like IF synemin have less body mass, too (Garcia-Pelagio et al., 2015). As 
nestin is a very minor IF in the muscle, the effect of its absence on muscle and 
body mass points towards a novel and rather surprising role for nestin in muscle 
homeostasis. 
5.6 The role of nestin in muscle differentiation and 
regeneration (II) 
The results from the EcoMRI and muscle mass studies showed nestin-/- mice to 
have less muscle mass. To investigate if this loss of muscle mass is companioned 
with morphological changes in the muscles, histological samples from several 
skeletal muscles were examined. Sections of soleus, EDL and TA muscles showed 
that although nestin-/- muscle does not show any gross abnormality, the number 
of regenerating myofibers, as determined by the presence of centrally located 
nuclei (CLN) in myofibers, is higher in the absence of nestin (II Figure 2). The 
increased amount of CLN is most prominent in the TA and soleus muscles, 
which reflects their weight bearing function. Although the trend for more 
regenerating myofibers is strong in the nestin-/- animals, it is important to notice 
that the variation between animals is large; some of the knockouts show 
seemingly normal muscles, whereas others have a prominent regenerative 
phenotype. Our results show that in the absence of nestin, muscle fibers undergo 
degradation and regeneration more frequently, and that regeneration is triggered 
by normal stress like the everyday use of the muscles.     
In previous studies, the dynamics of nestin expression after muscle injury has 
been addressed (Čížková et al., 2009; Vaittinen et al., 2001), but the functions of 
nestin in muscle regeneration have not yet been investigated. Utilizing the 
nestin-/- mice, we looked into the function of nestin during in vivo-muscle 
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regeneration. The TA muscle of 2-month-old mice was injured by an incision 
through half of the muscle thickness: this cutting type injury mimics a traumatic 
muscle injury. By staining tissue sections harvested at different time points after 
the injury against nestin, we confirmed that nestin is upregulated after muscle 
injury (II Figure 5). We also showed that the dynamics in mice differ slightly 
from the previously published results acquired from rats (Vaittinen et al., 1999). 
Furthermore, we prove that nestin is an important part of the muscle 
regeneration process. In the absence of nestin, the regeneration is prolonged, as 
evident from more regenerating myofibers being detected 28 days after the 
muscle injury.   
Interestingly, the synemin-/- mice show a similar increase in CLN, but also in cell 
membrane defects (Li et al., 2014). The membrane injuries in the synemin-/- mice 
could be due to the fact that synemin binds to several proteins important for 
membrane structure, such as plectin (Li et al., 2014). In the case of nestin, little is 
known about its binding partners, but as nestin specifically localizes to the MTJ 
(Vaittinen et al., 1999), nestin might take part in the organization of these, or in 
their functions. The formation of new MTJs, and the attachment of newly 
formed myotubes to the connective tissue, is part of the last steps of the 
regeneration process. As our study shows that the absence of nestin prolongs the 
regeneration process, it is indeed tempting to speculate that the formation of 
functional MTJs in the nestin-/- mice is impaired, and that this affects the 
regeneration. Both nestin and synemin are minor IFs in the skeletal muscle, and 
yet these proteins play important roles in preserving muscle homeostasis and in 
protecting from stress. 
In summary, our results demonstrate that although nestin is not needed for 
normal baseline muscle function, nestin plays important roles in protecting the 
muscles from stress. This is evident, as the phenotypes of the nestin-/- mice 
worsen with age and injury induced stress.    
5.7 Nestin affects male characteristics (unpublished) 
Nestin has been detected in the Leydig and Sertoli cells of the testis during 
development and in neoplasia (Davidoff et al., 2004; Fröjdman et al., 1997; Lobo 
et al., 2004). Although nestin expression has been identified in specific testicular 
cells, nothing is known about nestin function in the testis. We used a lack of 
function-approach to improve the understanding of the role of nestin in the 
Results and Discussion 
64 
 
testis. Therefore, we analyzed various parameters of the testes from nestin-/- 
animals.  
Firstly, we detected that the individual testis weight variation was slightly 
enhanced between animals and significantly enhanced in individual animals in 
mice lacking nestin (Figure 11). Interestingly, there is no difference in the 
combined testis weight between wt and nestin-/- mice, nor is the fertility affected 
(data not shown). As nestin has been reported to be expressed in Leydig cells, the 
main testosterone-producing cells in the male, we wanted to investigate if nestin 
affects the testosterone processing. Serum testosterone levels were measured 
from 3-month-old wild type and nestin-/- mice (Figure 12). Although no 
significant differences were detected, nestin-/- mice tended to have lower serum 
testosterone levels. However, as the variation between animals is very large also 
in wt mice, measurements of serum testosterone levels give limited information 
about gonad function.  
   
Figure 11. Nestin-/- mice have greater variance in testicular weight.  A, Single 
testicle weight from 3-month-old wild type and nestin-/- mice expressed as percent 
of body weight. Each circle represents one testicle and the line connects the testes 
from the same animal. B, Average inter-animal difference in testicular weight. The 
nestin-/- mice have a greater size variance between their testes, indicating that 
nestin has a role in building or maintaining testicular weight in mice. WT, n=41, 
KO n=33, ** p=0.0072 using unpaired t test with Welch's correction.  
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Figure 12. Serum testosterone is not significantly altered in nestin-/- mice. Serum 
testosterone levels were determined from 3-month-old male mice. Although the 
nestin-/- mice tend to have lower testosterone levels (average 6.171 ± 2.185 nM, 
N=27) than wild type mice (average 9.474 ± 2.888 nM, N=27), the difference is not 
significant.  
Deletion of vimentin from mice has been shown to affect steroidogenesis in 
ovaries and adrenal cortex, but not in testis (Shen et al., 2012). The vimentin-/- 
mice did not show any changes in serum testosterone levels or in testosterone 
production from isolated Leydig cells (Shen et al., 2012). However, no data is 
available on testis size in the absence of vimentin. As vimentin is strongly 
expressed in the Leydig and Sertoli cells (Lydka et al., 2011; Ortega et al., 2004), a 
comparison of the testes from mice lacking vimentin, and thus nestin filaments 
(Eliasson et al., 1999), with the testes from mice lacking nestin would be of 
interest. 
In summary, our results indicate that the highly regulated processes controlling 
testicular weight and appearance are more prone to failure in the absence of 
nestin, but also that this imbalance does not have dramatic effects on testicular 
function. The source of this, however, remains unidentified; given that nestin has 
been identified in the Leydig stem cells (Jiang et al., 2014), a depletion of them or 
malfunction in their recruitment or proliferation seems plausible. A detailed 
study of the testis and its different cell types in absence of nestin is needed to 
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understand the different functions of nestin in this tissue. As elevated expression 
of nestin has been reported in human testicular cancer (Lobo et al., 2004), deeper 
knowledge of the function of nestin and the processes it controls in the testis can 
indeed have clinical significance.  
5.8 Expression of human vimentin in Drosophila (III) 
As noted earlier, the use of mice in IF-research has its limitations. Apart from 
the IF-specific shortcomings, cost, generation length and ethics are major 
considerations for the use of mice. The fruit fly D. melanogaster is a widely used 
laboratory animal, which has a short generation turnover and is cost-efficient to 
use. As noted earlier, arthropods lack cytoplasmic IFs, a trait that makes them 
ideal for the study of intrinsic IF functions in the absence of interacting and 
compensatory mechanisms. Furthermore, the expression of a cytoplasmic IF in 
an arthropod could give insight into why these animals lack cytoplasmic IFs, and 
if any compatibility between IFs and the Drosophila cytoskeleton exists. The 
formation of an IF-network in Drosophila and/or interactions between the 
introduced IF and the endogenous Drosophila proteins could indicate that close 
ancestors of the Drosophila have harboured functional IFs later lost during 
evolution.  
Flies ubiquitously expressing vimentin were constructed using recombinant 
DNA technology. The vimentin flies were apparently normal, with a weight and 
lifespan indistinguishable from control flies (III Figure 3). This finding shows 
that vimentin is not toxic to Drosophila, as also keratin 5/14 has been proven 
non-toxic to flies (Bohnekamp et al., 2015). Taken together, this strongly 
suggests that cytoplasmic IFs are not harmful to Drosophila. After establishing 
this, we looked further into how vimentin is behaving in a Drosophila 
environment. We showed that although the mRNA expression levels of vimentin 
are the same in the whole fly, vimentin, surprisingly, appears to be stabilised at 
the protein level in certain parts of the body (III Figure 4). This stabilisation is 
difficult to explain, and its confirmation requires more detailed biochemical 
analyses to be performed.   
In mammals vimentin has important functions during wound healing, as shown 
by the delayed wound healing in mice lacking vimentin (Eckes et al., 2000). 
Drosophila can be used to study wound healing, although some of the 
mechanisms of healing differ between mammals and flies; reviewed in (Belacortu 
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and Paricio, 2011). To investigate if the introduction of vimentin could affect 
wound healing in the Drosophila model, as well as related processes, such as cell 
migration and differentiation, could be of interest.  
The establishment of the keratin 5/14-expressing fly and the Drosophila model 
of EBS (Bohnekamp et al., 2015), as well as our vimentin fly, has opened up a 
new path in the IF-field. These proof-of-concept studies offer a new way of 
studying both structure and function of IFs, and especially IF mutations. These 
studies can also give insights into the evolution of IFs and the remaining 
question of why arthropods lack cytoplasmic IFs.  
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6 Concluding Remarks  
IFs function as cellular scaffolds, signalling transducers and organisers; IFs are 
needed for proper healing after injury and protect against stress; in line with this, 
mutations in IFs give rise to a wide variety of diseases. Still, many of the exact 
cellular roles of IFs and how they are regulated remain unknown. The work in 
this thesis gives insight into the diverse roles of IFs. 
Lamin A/C is present in almost all differentiated cell types, yet mutations in it 
give rise to tissue specific diseases. To understand why this is and how we can 
relieve these diseases, we have to gain deeper knowledge about the functions of 
lamin A/C under normal conditions, as well as the processes that regulate these 
functions. Phosphorylation is the predominant PTM of lamin A/C. Even though 
many phosphorylation sites had been identified previously, our work offers a 
new understanding of how phosphorylation affects lamin A in interphase cells. 
By looking at how mutations of phosphorylation sites affect lamin A dynamics, 
we were able to define a new mechanism that regulates the ratio of lamina-
bound and nucleoplasmic lamin A, as well as lamin A movements. This opens 
up for future studies of the roles of lamin A localization and dynamics in e.g. cell 
signalling and transcription.   
Nestin has been known to be expressed in muscle during development and 
regeneration; the roles of nestin in these contexts have, however, remained 
unknown. Our study of the nestin-/- mouse is the first thorough investigation of 
the functions of nestin in healthy and injured muscle. We also show that nestin 
regulates body weight and composition. As we looked further into the effect of 
nestin ablation on animals, we discovered that nestin-/- mice have a great 
variation in testicle size. The indications that nestin has a role as a protector of 
tissue homeostasis in several different tissues are reinforced when these results 
are combined. Plausibly, nestin acts as a stress protector by regulating signalling 
cascades. The findings are in line with previous reports of other IF knockout 
mice, underlining the role of IFs as stress protectors and regulators of tissue 
homeostasis.  
We show that it is possible to express human vimentin in Drosophila, and that 
vimentin is not harmful to the flies. The vimentin expressing Drosophila model 
is a new tool in IF research and can be utilized for further studies both of 
vimentin function and structure as well as arthropod evolution.  
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The work in this thesis highlights how small changes at protein level can have 
profound effects on cells and cell signalling. Furthermore, my work shows that 
even obscure proteins with limited expression patterns can influence the whole 
body, and have unexpected functions.   
Figure 13. Multilevel impact of IFs. The presence or absence as well as the form of 
IFs have profound effects on cellular processes, such as proliferation, migration, 
differentiation and survival. These processes also affect the IFs by, for example, 
changing their phosphorylation. Phosphorylation regulates IF dynamics, 
localisation, and degradation; this in turn influences cellular decisions such as 
whether to migrate, proliferate or differentiate. An organism without an IF, or 
with a faulty IF, can develop a distinct phenotype, such as a disease. These 
phenotypes are dependent on the cellular changes that IFs induce, but may also 
induce changes in other IFs such as the compensatory expression of an otherwise 
non-expressed IF.    
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